☰

Robert Charles Gallo - Publications

Affiliations: 
Institute of Human Virology University of Maryland, College Park, College Park, MD 
Area:
Virology, retroviruses, HIV
Website:
http://www.ihv.org/about/bios/gallo.html
Tree Info Similar researchers PubMed Report error

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Gallo R, Buanec H, Schiavon V, Mérandet M, Howkit A, Song H, Bergerat D, C FL, Bensussan A, Bouaziz JD, Burny A, Darcis G, Sajadi M, Kottilil S, Zagury D. IFNα induces CCR5 in CD4+ T-cells, causing its anti- HIV inefficiency and its subsequent pathogenic elevation, partially controlled by anti-HIV therapy. Research Square. PMID 37214795 DOI: 10.21203/rs.3.rs-2813616/v1  0.319
2020 Benedetti F, Snyder GA, Giovanetti M, Angeletti S, Gallo RC, Ciccozzi M, Zella D. Emerging of a SARS-CoV-2 viral strain with a deletion in nsp1. Journal of Translational Medicine. 18: 329. PMID 32867854 DOI: 10.1186/S12967-020-02507-5  0.31
2020 Gallo RC. HIV/AIDS Research for the Future. Cell Host & Microbe. 27: 499-501. PMID 32272074 DOI: 10.1016/J.Chom.2020.03.022  0.339
2020 Benedetti F, Cocchi F, Latinovic OS, Curreli S, Krishnan S, Munawwar A, Gallo RC, Zella D. Role of Mycoplasma Chaperone DnaK in Cellular Transformation. International Journal of Molecular Sciences. 21. PMID 32075244 DOI: 10.3390/Ijms21041311  0.315
2020 Stafford KA, Mayer BT, Fulp W, Chua J, Davis C, Gilliam B, Dong D, Gallo RC, Sajadi MM. Variability of CD4+ cell counts in HIV-1 uninfected volunteers who are eligible for a Phase I HIV vaccine study. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 31985697 DOI: 10.1097/Qai.0000000000002306  0.322
2019 Tagaya Y, Matsuoka M, Gallo R. 40 years of the human T-cell leukemia virus: past, present, and future. F1000research. 8. PMID 30854194 DOI: 10.12688/F1000Research.17479.1  0.395
2019 Sui Y, Lewis GK, Wang Y, Berckmueller K, Frey B, Dzutsev A, Vargas-Inchaustegui D, Mohanram V, Musich T, Shen X, DeVico A, Fouts T, Venzon D, Kirk J, Waters RC, ... ... Gallo RC, et al. Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response. The Journal of Clinical Investigation. PMID 30776026 DOI: 10.1172/Jci122110  0.377
2018 Wu L, Zhang H, Jiang Y, Gallo RC, Cheng H. Induction of antitumor cytotoxic lymphocytes using engineered human primary blood dendritic cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 29674449 DOI: 10.1073/Pnas.1800550115  0.316
2018 Wu L, Zhang H, Jiang Y, Gallo R, Cheng H. B-106 Development of anti-tumor cytotoxic lymphocytes using engineered human primary blood dendritic cells Journal of Acquired Immune Deficiency Syndromes. 77: 37. DOI: 10.1097/01.Qai.0000532587.44307.D0  0.304
2017 Mengistu M, Tang AH, Foulke JS, Blanpied TA, Gonzalez MW, Spouge JL, Gallo RC, Lewis GK, DeVico AL. Patterns of conserved gp120 epitope presentation on attached HIV-1 virions. Proceedings of the National Academy of Sciences of the United States of America. PMID 29087304 DOI: 10.1073/Pnas.1705074114  0.424
2017 Tagaya Y, Gallo RC. The Exceptional Oncogenicity of HTLV-1. Frontiers in Microbiology. 8: 1425. PMID 28824561 DOI: 10.3389/Fmicb.2017.01425  0.423
2017 Li G, Poulsen M, Fenyvuesvolgyi C, Yashiroda Y, Yoshida M, Simard JM, Gallo RC, Zhao RY. Characterization of cytopathic factors through genome-wide analysis of the Zika viral proteins in fission yeast. Proceedings of the National Academy of Sciences of the United States of America. PMID 28049830 DOI: 10.1073/Pnas.1619735114  0.324
2017 Carroll V, Lafferty M, Marchionni L, Bryant J, Gallo R, Garzino-Demo A. P-A6 Expression of HIV-1 matrix protein p17 and correlation with B cell lymphoma in HIV-1 transgenic mice Journal of Acquired Immune Deficiency Syndromes. 74: 73. DOI: 10.1097/01.Qai.0000513909.57423.Ad  0.339
2017 Dieffenbach C, Gallo R. A-110 Special panel discussion on HIV cure research Journal of Acquired Immune Deficiency Syndromes. 74: 38. DOI: 10.1097/01.Qai.0000513820.11336.99  0.316
2016 Gallo RC, Willems L, Hasegawa H. Screening transplant donors for HTLV-1 and -2. Blood. 128: 3029-3031. PMID 28034870 DOI: 10.1182/Blood-2016-09-739433  0.402
2016 Willems L, Hasegawa H, Accolla R, Bangham C, Bazarbachi A, Bertazzoni U, Carneiro-Proietti AB, Cheng H, Chieco-Bianchi L, Ciminale V, Coelho-Dos-Reis J, Esparza J, Gallo RC, Gessain A, Gotuzzo E, et al. Reducing the global burden of HTLV-1 infection: An agenda for research and action. Antiviral Research. PMID 27840202 DOI: 10.1016/J.Antiviral.2016.10.015  0.402
2016 Carroll VA, Lafferty MK, Marchionni L, Bryant JL, Gallo RC, Garzino-Demo A. Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 27799525 DOI: 10.1073/Pnas.1615258113  0.417
2016 Gallo RC. Shock and kill with caution. Science (New York, N.Y.). 354: 177-178. PMID 27738158 DOI: 10.1126/Science.Aaf8094  0.421
2016 Nolte-'t Hoen E, Cremer T, Gallo RC, Margolis LB. Extracellular vesicles and viruses: Are they close relatives? Proceedings of the National Academy of Sciences of the United States of America. PMID 27432966 DOI: 10.1073/Pnas.1605146113  0.379
2016 Schwartz JA, Prado I, Misamore J, Weiss D, Francis J, Pal R, Huaman M, Cristillo A, Lewis GK, Gallo RC, DeVico AL, Fouts TR. An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques. Clinical and Vaccine Immunology : Cvi. PMID 27193040 DOI: 10.1128/Cvi.00115-16  0.34
2016 He W, Campilongo F, Caccuri F, Yuan W, Varney K, Caruso A, Gallo R, Lu W. F-103 A conformational switch that turns on the B cell growth- promoting activity of the HIV-1 matrix protein p17 Journal of Acquired Immune Deficiency Syndromes. 71: 61. DOI: 10.1097/01.Qai.0000479626.70515.0C  0.32
2015 Dolcetti R, Giagulli C, He W, Selleri M, Caccuri F, Eyzaguirre LM, Mazzuca P, Corbellini S, Campilongo F, Marsico S, Giombini E, Muraro E, Rozera G, De Paoli P, Carbone A, ... ... Gallo RC, et al. Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 112: 14331-6. PMID 26578780 DOI: 10.1073/Pnas.1514748112  0.379
2015 DeVico AL, Lewis GK, Gallo RC. Modulating the durability of anti-HIV gp120 antibody responses after vaccination: a comment on Wilson & Karp (2015). Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 370. PMID 26460138 DOI: 10.1098/Rstb.2015.0199  0.314
2015 Basta D, Latinovic O, Lafferty MK, Sun L, Bryant J, Lu W, Caccuri F, Caruso A, Gallo R, Garzino-Demo A. Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. Pathogens and Disease. 73. PMID 26333571 DOI: 10.1093/Femspd/Ftv062  0.341
2015 Heredia A, Le N, Gartenhaus RB, Sausville E, Medina-Moreno S, Zapata JC, Davis C, Gallo RC, Redfield RR. Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice. Proceedings of the National Academy of Sciences of the United States of America. 112: 9412-7. PMID 26170311 DOI: 10.1073/Pnas.1511144112  0.363
2015 Gallo RC. Developing a Successful HIV Vaccine. The Journal of Infectious Diseases. 212: S40-1. PMID 26116730 DOI: 10.1093/Infdis/Jiv069  0.399
2015 Fouts TR, Bagley K, Prado IJ, Bobb KL, Schwartz JA, Xu R, Zagursky RJ, Egan MA, Eldridge JH, LaBranche CC, Montefiori DC, Le Buanec H, Zagury D, Pal R, Pavlakis GN, ... ... Gallo RC, et al. Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection. Proceedings of the National Academy of Sciences of the United States of America. 112: E992-9. PMID 25681373 DOI: 10.1097/01.Qai.0000479717.30834.7D  0.381
2015 Gallo RC. A historical personal perspective on human retroviruses and their infection of T cells. Transfusion. 55: 1-9. PMID 25413015 DOI: 10.1111/Trf.12935  0.386
2014 Thomas MA, Tuero I, Demberg T, Vargas-Inchaustegui DA, Musich T, Xiao P, Venzon D, LaBranche C, Montefiori DC, DiPasquale J, Reed SG, DeVico A, Fouts T, Lewis GK, Gallo RC, et al. HIV-1 CD4-induced (CD4i) gp120 epitope vaccines promote B and T-cell responses that contribute to reduced viral loads in rhesus macaques. Virology. 471: 81-92. PMID 25461534 DOI: 10.1016/J.Virol.2014.10.001  0.39
2014 Lewis GK, DeVico AL, Gallo RC. Antibody persistence and T-cell balance: two key factors confronting HIV vaccine development. Proceedings of the National Academy of Sciences of the United States of America. 111: 15614-21. PMID 25349379 DOI: 10.1073/Pnas.1413550111  0.348
2014 Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ, Gallo RC, Blattner WA. Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications. Jama. 312: 442. PMID 25038372 DOI: 10.1001/Jama.2013.279636  0.336
2014 Goicochea M, Nata T, Gallo R, Cheng H, Tagaya Y. HBZ RNA may promote cell survival against clastogenic damages and thereby contributes to the development of leukemic ATL cells Retrovirology. 11: 1-1. DOI: 10.1186/1742-4690-11-S1-O56  0.418
2014 Reitz MS, Gallo RC. Human Immunodeficiency Viruses Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2: 2054-2065.e3. DOI: 10.1016/B978-1-4557-4801-3.00171-5  0.381
2013 Curreli S, Krishnan S, Reitz M, Lunardi-Iskandar Y, Lafferty MK, Garzino-Demo A, Zella D, Gallo RC, Bryant J. B cell lymphoma in HIV transgenic mice. Retrovirology. 10: 92. PMID 23985023 DOI: 10.1186/1742-4690-10-92  0.392
2013 Guan Y, Pazgier M, Sajadi MM, Kamin-Lewis R, Al-Darmarki S, Flinko R, Lovo E, Wu X, Robinson JE, Seaman MS, Fouts TR, Gallo RC, DeVico AL, Lewis GK. Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding. Proceedings of the National Academy of Sciences of the United States of America. 110: E69-78. PMID 23237851 DOI: 10.1073/Pnas.1217609110  0.334
2013 Guan Y, Yu L, Zhan M, Gallo RC, Liu T, Sajadi M, DeVico AL, Lewis GK. E106 Diversity of Antibody Germline Gene and HIV-1 Infection Jaids Journal of Acquired Immune Deficiency Syndromes. 62: S53. DOI: 10.1097/01.Qai.0000429244.16910.D3  0.359
2012 Le Buanec H, Bensussan A, Bagot M, Gallo RC, Zagury D. Active and passive anticytokine immune therapies: current status and development. Advances in Immunology. 115: 187-227. PMID 22608260 DOI: 10.1016/B978-0-12-394299-9.00007-2  0.312
2012 Cocchi F, DeVico AL, Lu W, Popovic M, Latinovic O, Sajadi MM, Redfield RR, Lafferty MK, Galli M, Garzino-Demo A, Gallo RC. Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases. Proceedings of the National Academy of Sciences of the United States of America. 109: 5411-6. PMID 22431590 DOI: 10.1073/Pnas.1202240109  0.389
2012 Buanec HL, Sené T, Bensussan A, Gallo R, Zagury D. The dual (activating/suppressive) effect of extracellular TatHIV-1 is driven by the infalmmatory microenvironment of infected lymphoid foci Retrovirology. 9: 35. DOI: 10.1186/1742-4690-9-S1-P35  0.418
2012 Gallo R. HIV prevention by vaccine Retrovirology. 9: 1-1. DOI: 10.1186/1742-4690-9-S1-I5  0.4
2012 Gallo R. A global virus network and a perspective on viral infections in humans Retrovirology. 9: 1-1. DOI: 10.1186/1742-4690-9-S1-I22  0.326
2012 Guan Y, Pazgier M, Sajadi M, Damarki SA, Meginstu M, Wu X, Gallo RC, Kamin-Lewis R, DeVico AL, Lewis GK. 112 Diversity of Specificity and Function Among Human Antibodies to Transitional Epitopes Altered by CD4 Binding to the HIV-1 Env Glycoprotein Journal of Acquired Immune Deficiency Syndromes. 59: 45. DOI: 10.1097/01.Qai.0000413731.29857.F7  0.348
2011 Gallo RC. Research and discovery of the first human cancer virus, HTLV-1. Best Practice & Research. Clinical Haematology. 24: 559-65. PMID 22127321 DOI: 10.1016/J.Beha.2011.09.012  0.436
2011 Guan Y, Lewis RK, Darmaki SA, Lovo E, Sajadi M, Redfield R, Gallo R, DeVico A, Lewis GK. 220 Novel Functional mAbs Against HIV-1 Gp120 from HIV Controller Journal of Acquired Immune Deficiency Syndromes. 56: 95. DOI: 10.1097/01.Qai.0000397402.27996.Da  0.342
2011 Fouts T, Lewis G, Pal R, Gallo R, DeVico A. 144 Protection Against Heterologous SHIV Challenge Afforded by Immunization of Rhesus Macaques With a Subunit Immunogen that Mimics a Transition State HIV Envelope Structure Journal of Acquired Immune Deficiency Syndromes. 56: 59. DOI: 10.1097/01.Qai.0000397330.72363.4A  0.319
2011 Latinovic O, Heredia A, Gallo RC, Redfield RR. 128 Suppression of CCR5 Density as a Novel Way to Enhance the Anti-HIV Activity of Fusion Inhibitors and CCR5 Antagonists Journal of Acquired Immune Deficiency Syndromes. 56: 52. DOI: 10.1097/01.Qai.0000397316.47707.8B  0.322
2010 Gallo RC. 25 years after discovering HIV as the cause of aids: prospects for a vaccine Retrovirology. 7: 1-2. DOI: 10.1186/1742-4690-7-S1-K1  0.341
2009 Biancotto A, Grivel JC, Lisco A, Vanpouille C, Markham PD, Gallo RC, Margolis LB, Lusso P. Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A. Retrovirology. 6: 61. PMID 19573243 DOI: 10.1186/1742-4690-6-61  0.363
2009 Latinovic O, Heredia A, Gallo RC, Reitz M, Le N, Redfield RR. Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonists. Antiviral Research. 83: 86-9. PMID 19501260 DOI: 10.1016/J.Antiviral.2009.02.199  0.362
2009 Guan Y, Sajadi MM, Kamin-Lewis R, Fouts TR, Dimitrov A, Zhang Z, Redfield RR, DeVico AL, Gallo RC, Lewis GK. Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America. 106: 3952-7. PMID 19225108 DOI: 10.1073/Pnas.0813392106  0.388
2009 Buonaguro L, Tornesello ML, Gallo RC, Marincola FM, Lewis GK, Buonaguro FM. Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles. Journal of Virology. 83: 304-13. PMID 18945779 DOI: 10.1128/Jvi.01606-08  0.432
2009 Gallo RC. Toward an HIV preventive vaccine: problems and prospects Retrovirology. 6: I3. DOI: 10.1186/1742-4690-6-S2-I3  0.373
2009 Guan Y, Sajadi M, DeVico AL, Obriecht C, Flinko R, Godfrey K, Fouts T, Pal R, Redfield R, Gallo R, Lewis GK. 221 Humoral Immunity against Conserved Epitopes of HIV-1 Envelope Protein Archived in Memory B cells in Natural Viral Suppressors: Discordance with Plasma Antibodies Journal of Acquired Immune Deficiency Syndromes. 51: 1. DOI: 10.1097/01.Qai.0000351177.71714.51  0.372
2009 Buonaguro L, Tornesello ML, Gallo RC, Marincola FM, Lewis GK, Buonaguro FM. 210 Peripheral blood mononuclear cells activated by HIV-VLPs in correlation with HIV-1 seropositivity status Journal of Acquired Immune Deficiency Syndromes. 51: 1. DOI: 10.1097/01.Qai.0000351166.03102.Bb  0.366
2009 Cocchi F, DeVico A, Demo AG, Gallo RC. 187 Autoresistance to X4 HIV Infection by soluble suppressor factors secreted from CD4+ T cells Journal of Acquired Immune Deficiency Syndromes. 51: 1. DOI: 10.1097/01.Qai.0000351142.25080.C3  0.39
2008 Heredia A, Latinovic O, Gallo RC, Melikyan G, Reitz M, Le N, Redfield RR. Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1. Proceedings of the National Academy of Sciences of the United States of America. 105: 20476-81. PMID 19075241 DOI: 10.1073/Pnas.0810843106  0.355
2008 Lehmann C, Harper JM, Taubert D, Hartmann P, Fätkenheuer G, Jung N, van Lunzen J, Stellbrink HJ, Gallo RC, Romerio F. Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). 48: 522-30. PMID 18645522 DOI: 10.1097/Qai.0B013E31817F97Cf  0.352
2007 DeVico A, Fouts T, Lewis GK, Gallo RC, Godfrey K, Charurat M, Harris I, Galmin L, Pal R. Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens. Proceedings of the National Academy of Sciences of the United States of America. 104: 17477-82. PMID 17956985 DOI: 10.1073/Pnas.0707399104  0.346
2007 Heredia A, Gilliam B, DeVico A, Le N, Bamba D, Flinko R, Lewis G, Gallo RC, Redfield RR. CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1. Aids (London, England). 21: 1317-22. PMID 17545708 DOI: 10.1097/Qad.0B013E32815278Ea  0.418
2007 Heredia A, Gilliam B, Latinovic O, Le N, Bamba D, Devico A, Melikyan GB, Gallo RC, Redfield RR. Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro. Antimicrobial Agents and Chemotherapy. 51: 2489-96. PMID 17485501 DOI: 10.1128/Aac.01602-06  0.429
2007 Lusso P, Crowley RW, Malnati MS, Di Serio C, Ponzoni M, Biancotto A, Markham PD, Gallo RC. Human herpesvirus 6A accelerates AIDS progression in macaques. Proceedings of the National Academy of Sciences of the United States of America. 104: 5067-72. PMID 17360322 DOI: 10.1073/Pnas.0700929104  0.364
2007 Kish-Catalone T, Pal R, Parrish J, Rose N, Hocker L, Hudacik L, Reitz M, Gallo R, Devico A. Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model. Aids Research and Human Retroviruses. 23: 33-42. PMID 17263630 DOI: 10.1089/Aid.2006.0076  0.401
2007 Blayney DW, Blattner WA, Jaffe ES, Gallo RC. Retroviruses in human leukemia Hematological Oncology. 1: 193-204. PMID 6329935 DOI: 10.1002/Hon.2900010302  0.39
2006 Gallo RC. A perspective on human herpes virus 6 (HHV-6). Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 37: S2. PMID 17276365 DOI: 10.1016/S1386-6532(06)70003-8  0.37
2006 Gallo R. Bringing basic science back to centre stage to fight HIV/AIDS The Lancet. 368: 1861-1862. PMID 17131524 DOI: 10.1016/S0140-6736(06)69760-2  0.315
2006 Gallo RC. A reflection on HIV/AIDS research after 25 years. Retrovirology. 3: 72. PMID 17054781 DOI: 10.1186/1742-4690-3-72  0.301
2006 Buonaguro L, Tornesello ML, Tagliamonte M, Gallo RC, Wang LX, Kamin-Lewis R, Abdelwahab S, Lewis GK, Buonaguro FM. Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. Journal of Virology. 80: 9134-43. PMID 16940524 DOI: 10.1128/Jvi.00050-06  0.439
2006 Kish-Catalone TM, Lu W, Gallo RC, DeVico AL. Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5. Antimicrobial Agents and Chemotherapy. 50: 1497-509. PMID 16569870 DOI: 10.1128/Aac.50.4.1497-1509.2006  0.38
2006 Lusso P, Crowley RW, Malnati MS, Ponzoni M, Serio CD, Biancotto A, Markham PD, Gallo RC. Accelerated progression to AIDS in macaques coinfected with simian immunodeficiency virus and human herpesvirus 6A Retrovirology. 3: 1-1. DOI: 10.1186/1742-4690-3-S1-S62  0.399
2006 Gallo RC. A brief history of AIDS Bmj. 333: 612450. DOI: 10.1136/Sbmj.0612450  0.316
2005 Trujillo JR, Jaramillo-Rangel G, Ortega-Martinez M, Penalva de Oliveira AC, Vidal JE, Bryant J, Gallo RC. International NeuroAIDS: prospects of HIV-1 associated neurological complications. Cell Research. 15: 962-9. PMID 16354575 DOI: 10.1038/Sj.Cr.7290374  0.365
2005 Gallo RC. Commentary remarks on "HIV/AIDS in China". Cell Research. 15: 823. PMID 16354553 DOI: 10.1038/Sj.Cr.7290352  0.335
2005 Heredia A, Davis C, Bamba D, Le N, Gwarzo MY, Sadowska M, Gallo RC, Redfield RR. Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication. Aids (London, England). 19: 2087-95. PMID 16284457 DOI: 10.1097/01.Aids.0000194805.74293.11  0.392
2005 Popovic M, Tenner-Racz K, Pelser C, Stellbrink HJ, van Lunzen J, Lewis G, Kalyanaraman VS, Gallo RC, Racz P. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proceedings of the National Academy of Sciences of the United States of America. 102: 14807-12. PMID 16199516 DOI: 10.1073/Pnas.0506857102  0.412
2005 Gallo RC. History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene. 24: 5926-30. PMID 16155599 DOI: 10.1038/Sj.Onc.1208980  0.449
2005 Gallo RC. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology. 2: 17. PMID 15743526 DOI: 10.1186/1742-4690-2-17  0.397
2005 Buonaguro L, Tornesello M, Aricò E, Marincola F, Lewis-Kamin R, Gallo R, Lewis G, Buonaguro F. Baculovirus-Derived HIV-1 Virus-Like Particles (VLP) Activate Dendritic Cells and Are Cross-Presented to Induce In Vitro T-Cell Response Retrovirology. 2: 1-1. DOI: 10.1186/1742-4690-2-S1-S70  0.39
2005 Zagury D, Buanec HL, Burny A, Gallo RC. Follow-up of HIV Infected Patients Who Received a Therapeutic Anti-Tat Vaccination Retrovirology. 2: 1-1. DOI: 10.1186/1742-4690-2-S1-S115  0.321
2005 Heredia A, Amoroso A, Davis C, Le N, Bamba D, Gallo R, Redfield R. The Immunomodulatory Agent Rapamycin Potentiates the Antiviral Activity of the Fusion Inhibitor T20 Against R5 Strains of HIV-1 Retrovirology. 2: 134. DOI: 10.1186/1742-4690-2-S1-P134  0.364
2005 Gallo RC. Tackling HIV/AIDS: more scientific truth, less bureaucracy The Lancet. 366: 1841-1842. DOI: 10.1016/S0140-6736(05)67741-0  0.333
2004 Wu Z, Alexandratos J, Ericksen B, Lubkowski J, Gallo RC, Lu W. Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation. Proceedings of the National Academy of Sciences of the United States of America. 101: 11587-92. PMID 15280532 DOI: 10.1073/Pnas.0404649101  0.317
2004 Gallo RC. HIV-1: a look back from 20 years. Dna and Cell Biology. 23: 191-2. PMID 15142376 DOI: 10.1089/104454904773819770  0.483
2004 DeVico AL, Gallo RC. Control of HIV-1 infection by soluble factors of the immune response. Nature Reviews. Microbiology. 2: 401-13. PMID 15100693 DOI: 10.1038/Nrmicro878  0.381
2004 Reid W, Abdelwahab S, Sadowska M, Huso D, Neal A, Ahearn A, Bryant J, Gallo RC, Lewis GK, Reitz M. HIV-1 transgenic rats develop T cell abnormalities. Virology. 321: 111-9. PMID 15033570 DOI: 10.1016/J.Virol.2003.12.010  0.399
2003 Gallo RC. A journey with T cells, primate/human retroviruses and other persisting human T-cell tropic viruses. Reviews in Clinical and Experimental Hematology. 7: 329-35. PMID 15129646  0.357
2003 Gallo RC, Montagnier L. The discovery of HIV as the cause of AIDS. The New England Journal of Medicine. 349: 2283-5. PMID 14668451 DOI: 10.1056/Nejmp038194  0.441
2003 Abdelwahab SF, Cocchi F, Bagley KC, Kamin-Lewis R, Gallo RC, DeVico A, Lewis GK. HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses. Proceedings of the National Academy of Sciences of the United States of America. 100: 15006-10. PMID 14657379 DOI: 10.1073/Pnas.2035075100  0.432
2003 Heredia A, Amoroso A, Davis C, Le N, Reardon E, Dominique JK, Klingebiel E, Gallo RC, Redfield RR. Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. Proceedings of the National Academy of Sciences of the United States of America. 100: 10411-6. PMID 12915736 DOI: 10.1073/Pnas.1834278100  0.38
2003 Garzino-Demo A, Gallo RC. HIV receptors on lymphocytes. Current Opinion in Hematology. 10: 279-83. PMID 12799533 DOI: 10.1097/00062752-200307000-00005  0.4
2002 Gallo RC, Montagnier L. Historical essay. Prospects for the future. Science (New York, N.Y.). 298: 1730-1. PMID 12459577 DOI: 10.1126/Science.1079864  0.366
2002 Gallo RC. Historical essay. The early years of HIV/AIDS. Science (New York, N.Y.). 298: 1728-30. PMID 12459576 DOI: 10.1126/Science.1078050  0.356
2002 Gallo RC. Human retroviruses after 20 years: a perspective from the past and prospects for their future control. Immunological Reviews. 185: 236-65. PMID 12190935 DOI: 10.1034/J.1600-065X.2002.18520.X  0.49
2002 De Francesco MA, Baronio M, Fiorentini S, Signorini C, Bonfanti C, Poiesi C, Popovic M, Grassi M, Garrafa E, Bozzo L, Lewis GK, Licenziati S, Gallo RC, Caruso A. HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor. Proceedings of the National Academy of Sciences of the United States of America. 99: 9972-7. PMID 12105273 DOI: 10.1073/Pnas.142274699  0.409
2002 Agwale SM, Shata MT, Reitz MS, Kalyanaraman VS, Gallo RC, Popovic M, Hone DM. A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice. Proceedings of the National Academy of Sciences of the United States of America. 99: 10037-41. PMID 12096189 DOI: 10.1073/Pnas.152313899  0.36
2002 Skurnick JH, Palumbo P, DeVico A, Shacklett BL, Valentine FT, Merges M, Kamin-Lewis R, Mestecky J, Denny T, Lewis GK, Lloyd J, Praschunus R, Baker A, Nixon DF, Stranford S, ... Gallo R, et al. Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. The Journal of Infectious Diseases. 185: 428-38. PMID 11865394 DOI: 10.1086/338830  0.427
2001 Denaro FJ, Hayes N, Jones O, McCready M, Gallo R, Davis H, Bryant J. Muscular Abnormalities in the HIV-1 Transgenic Rat. Thescientificworldjournal. 1: 51. PMID 30147512 DOI: 10.1100/Tsw.2001.183  0.321
2001 Denaro FJ, Hayes N, Jones O, McCready M, Davis H, Reid B, Gallo R, Bryant J. Peripheral Nerve Degeneration in the HIV-1 Transgenic Rat. Thescientificworldjournal. 1: 50. PMID 30147508 DOI: 10.1100/Tsw.2001.182  0.323
2001 Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O'Driscoll P, Huso D, Fouts T, Lewis G, Hill M, ... ... Gallo RC, et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proceedings of the National Academy of Sciences of the United States of America. 98: 9271-6. PMID 11481487 DOI: 10.1073/Pnas.161290298  0.416
2001 Kamin-Lewis R, Abdelwahab SF, Trang C, Baker A, DeVico AL, Gallo RC, Lewis GK. Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1beta. Proceedings of the National Academy of Sciences of the United States of America. 98: 9283-8. PMID 11470920 DOI: 10.1073/Pnas.161298998  0.354
2000 Garzino-Demo A, DeVico AL, Conant KE, Gallo RC. The role of chemokines in human immunodeficiency virus infection. Immunological Reviews. 177: 79-87. PMID 11138787 DOI: 10.1034/J.1600-065X.2000.17711.X  0.413
2000 Secchiero P, Zella D, Curreli S, Mirandola P, Capitani S, Gallo RC, Zauli G. Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication. Proceedings of the National Academy of Sciences of the United States of America. 97: 14620-5. PMID 11114167 DOI: 10.1073/Pnas.011512398  0.377
2000 Cocchi F, DeVico AL, Yarchoan R, Redfield R, Cleghorn F, Blattner WA, Garzino-Demo A, Colombini-Hatch S, Margolis D, Gallo RC. Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America. 97: 13812-7. PMID 11095721 DOI: 10.1073/Pnas.240469997  0.379
2000 Pauza CD, Trivedi P, Wallace M, Ruckwardt TJ, Le Buanec H, Lu W, Bizzini B, Burny A, Zagury D, Gallo RC. Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proceedings of the National Academy of Sciences of the United States of America. 97: 3515-9. PMID 10725402 DOI: 10.1073/Pnas.97.7.3515  0.441
2000 Zella D, Romerio F, Curreli S, Secchiero P, Cicala C, Zagury D, Gallo RC. IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 164: 2296-302. PMID 10679063 DOI: 10.4049/Jimmunol.164.5.2296  0.308
1999 Gosselin J, TomoIu A, Gallo RC, Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood. 94: 4210-9. PMID 10590066 DOI: 10.1182/Blood.V94.12.4210.424K07_4210_4219  0.352
1999 Gallo RC, Garzino-Demo A, DeVico AL. HIV infection and pathogenesis: what about chemokines? Journal of Clinical Immunology. 19: 293-9. PMID 10535605 DOI: 10.1023/A:1020539524373  0.383
1999 Garzino-Demo A, Moss RB, Margolick JB, Cleghorn F, Sill A, Blattner WA, Cocchi F, Carlo DJ, DeVico AL, Gallo RC. Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status. Proceedings of the National Academy of Sciences of the United States of America. 96: 11986-91. PMID 10518563 DOI: 10.1073/Pnas.96.21.11986  0.385
1999 Reitz MS, Nerurkar LS, Gallo RC. Perspective on Kaposi's sarcoma: facts, concepts, and conjectures. Journal of the National Cancer Institute. 91: 1453-8. PMID 10469745 DOI: 10.1093/Jnci/91.17.1453  0.413
1999 Gallo RC. Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine. Proceedings of the National Academy of Sciences of the United States of America. 96: 8324-6. PMID 10411869 DOI: 10.1073/Pnas.96.15.8324  0.459
1999 Monini P, Colombini S, Stürzl M, Goletti D, Cafaro A, Sgadari C, Buttò S, Franco M, Leone P, Fais S, Leone P, Melucci-Vigo G, Chiozzini C, Carlini F, Ascherl G, ... ... Gallo RC, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood. 93: 4044-58. PMID 10361101 DOI: 10.1182/Blood.V93.12.4044.412K39_4044_4058  0.404
1999 Secchiero P, Zella D, Capitani S, Gallo RC, Zauli G. Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 162: 2427-31. PMID 9973525  0.3
1999 Samaniego F, Bryant JL, Liu N, Karp JE, Sabichi AL, Thierry A, Lunardi-Iskandar Y, Gallo RC. Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin. Journal of the National Cancer Institute. 91: 135-43. PMID 9923854 DOI: 10.1093/Jnci/91.2.135  0.339
1999 Colombini-Hatch S, Ekman M, Ramazzotti E, Sadowska M, Biberfeld P, Ensoli B, Reitz M, Chatynn L, Albashi D, Gallo RC. HHV-8-LIKE VIRUS CAN INFECT CYNOMOLGUS MONKEYS Jaids: Journal of Acquired Immune Deficiency Syndromes. 21: A37. DOI: 10.1097/00126334-199905010-00132  0.366
1998 Secchiero P, Zella D, Barabitskaja O, Reitz MS, Capitani S, Gallo RC, Zauli G. Progressive and persistent downregulation of surface CXCR4 in CD4(+) T cells infected with human herpesvirus 7. Blood. 92: 4521-8. PMID 9845516 DOI: 10.1182/Blood.V92.12.4521.424K38_4521_4528  0.406
1998 Burns JM, Gallo RC, DeVico AL, Lewis GK. A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling. The Journal of Experimental Medicine. 188: 1917-27. PMID 9815269 DOI: 10.1084/Jem.188.10.1917  0.371
1998 Secchiero P, Bertolaso L, Casareto L, Gibellini D, Vitale M, Bemis K, Aleotti A, Capitani S, Franchini G, Gallo RC, Zauli G. Human herpesvirus 7 infection induces profound cell cycle perturbations coupled to disregulation of cdc2 and cyclin B and polyploidization of CD4(+) T cells. Blood. 92: 1685-96. PMID 9716597 DOI: 10.1182/Blood.V92.5.1685  0.391
1998 Garzino-Demo A, DeVico AL, Gallo RC. Chemokine receptors and chemokines in HIV infection. Journal of Clinical Immunology. 18: 243-55. PMID 9710741 DOI: 10.1023/A:1027329721892  0.41
1998 Gallo RC. Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma. Journal of the National Cancer Institute. Monographs. 55-7. PMID 9709304 DOI: 10.1093/Oxfordjournals.Jncimonographs.A024174  0.469
1998 Owman C, Garzino-Demo A, Cocchi F, Popovic M, Sabirsh A, Gallo RC. The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. Proceedings of the National Academy of Sciences of the United States of America. 95: 9530-4. PMID 9689114 DOI: 10.1073/Pnas.95.16.9530  0.387
1998 Secchiero P, Bertolaso L, Gibellini D, Ricci D, Bemis K, Capitani S, Gallo RC, Zauli G. Enforced expression of human bcl-2 in CD4+ T cells enhances human herpesvirus 7 replication and induction of cytopathic effects. European Journal of Immunology. 28: 1587-96. PMID 9603464 DOI: 10.1002/(Sici)1521-4141(199805)28:05<1587::Aid-Immu1587>3.0.Co;2-#  0.429
1998 Benson J, Chougnet C, Robert-Guroff M, Montefiori D, Markham P, Shearer G, Gallo RC, Cranage M, Paoletti E, Limbach K, Venzon D, Tartaglia J, Franchini G. Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure. Journal of Virology. 72: 4170-82. PMID 9557706 DOI: 10.1128/Jvi.72.5.4170-4182.1998  0.376
1998 Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury JF, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, Burny A, Gallo RC. Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proceedings of the National Academy of Sciences of the United States of America. 95: 3851-6. PMID 9520456 DOI: 10.1073/Pnas.95.7.3851  0.325
1998 Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proceedings of the National Academy of Sciences of the United States of America. 95: 3117-21. PMID 9501225 DOI: 10.1073/Pnas.95.6.3117  0.32
1998 Flamand L, Crowley RW, Lusso P, Colombini-Hatch S, Margolis DM, Gallo RC. Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proceedings of the National Academy of Sciences of the United States of America. 95: 3111-6. PMID 9501224 DOI: 10.1073/Pnas.95.6.3111  0.408
1998 Fiorelli V, Gendelman R, Sirianni MC, Chang HK, Colombini S, Markham PD, Monini P, Sonnabend J, Pintus A, Gallo RC, Ensoli B. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood. 91: 956-67. PMID 9446657 DOI: 10.1182/Blood.V91.3.956.956_956_967  0.412
1998 Zolla-Pazner S, Lubeck M, Xu S, Burda S, Natuk RJ, Sinangil F, Steimer K, Gallo RC, Eichberg JW, Matthews T, Robert-Guroff M. Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees. Journal of Virology. 72: 1052-9. PMID 9444999 DOI: 10.1128/Jvi.72.2.1052-1059.1998  0.441
1998 Zella D, Barabitskaja O, Burns JM, Romerio F, Dunn DE, Revello MG, Gerna G, Jr MSR, Gallo RC, Weichold FF. Interferon-γ Increases Expression of Chemokine Receptors CCR1, CCR3, and CCR5, But Not CXCR4 in Monocytoid U937 Cells Blood. 91: 4444-4450. DOI: 10.1182/Blood.V91.12.4444.412K46_4444_4450  0.382
1998 Colombini-Hatch S, Ramazzotti E, Chandran B, Kamin-Lewis R, Lewis G, Yarchoan R, Ensoli B, Gallo RC. INCREASED HUMAN HERPESVIRUS-8 COPY NUMBER AND VIRAL GENE EXPRESSION IN AIDS-KAPOSI'S SARCOMA PATIENTS PERIPHERAL BLOOD MONONUCLEAR CELLS CULTURED IN PRESENCE OF INFLAMMATORY CYTOKINES. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 17: A20. DOI: 10.1097/00042560-199804010-00051  0.366
1997 Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskandar Y, Gallo RC. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. Journal of the National Cancer Institute. 89: 1797-802. PMID 9392621 DOI: 10.1093/Jnci/89.23.1797  0.421
1997 Pal R, Garzino-Demo A, Markham PD, Burns J, Brown M, Gallo RC, DeVico AL. Inhibition of HIV-1 infection by the beta-chemokine MDC. Science (New York, N.Y.). 278: 695-8. PMID 9381181 DOI: 10.1126/Science.278.5338.695  0.457
1997 Secchiero P, Flamand L, Gibellini D, Falcieri E, Robuffo I, Capitani S, Gallo RC, Zauli G. Human Herpesvirus 7 induces CD4(+) T-cell death by two distinct mechanisms: necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells. Blood. 90: 4502-12. PMID 9373261 DOI: 10.1182/Blood.V90.11.4502.4502_4502_4512  0.402
1997 Garzino-Demo A, Arya SK, Devico AL, Cocchi F, Lusso P, Gallo RC. C-C chemokine RANTES and HIV long terminal repeat-driven gene expression. Aids Research and Human Retroviruses. 13: 1367-71. PMID 9359655 DOI: 10.1089/Aid.1997.13.1367  0.33
1997 Lori F, Gallo RC, Malykh A, Cara A, Romano J, Markham P, Franchini G. Didanosine but not high doses of hydroxyurea rescue pigtail macaque from a lethal dose of SIV(smmpbj14). Aids Research and Human Retroviruses. 13: 1083-8. PMID 9282812 DOI: 10.1089/Aid.1997.13.1083  0.326
1997 Lubeck MD, Natuk R, Myagkikh M, Kalyan N, Aldrich K, Sinangil F, Alipanah S, Murthy SC, Chanda PK, Nigida SM, Markham PD, Zolla-Pazner S, Steimer K, Wade M, Reitz MS, ... ... Gallo RC, et al. Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization. Nature Medicine. 3: 651-8. PMID 9176492 DOI: 10.1038/Nm0697-651  0.354
1997 Secchiero P, Sun D, De Vico AL, Crowley RW, Reitz MS, Zauli G, Lusso P, Gallo RC. Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans. Journal of Virology. 71: 4571-80. PMID 9151851 DOI: 10.1128/Jvi.71.6.4571-4580.1997  0.377
1997 Guo HG, Browning P, Nicholas J, Hayward GS, Tschachler E, Jiang YW, Sadowska M, Raffeld M, Colombini S, Gallo RC, Reitz MS. Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma. Virology. 228: 371-8. PMID 9123844 DOI: 10.1006/Viro.1996.8386  0.364
1997 Colombini-Hatch S, Trwniszewska E, Ramazzotti E, Rivardeneira E, Yarchoan R, Humphrey R, Ensoli B, Gallo RC. Isolation Of Human Herpesvirus-8 (Hhv-8) From Pbmc Of Aids-Ks Patients And Viral Transmission To Primary Cell Culture: 72 Journal of Acquired Immune Deficiency Syndromes. 14. DOI: 10.1097/00042560-199704010-00113  0.397
1997 Barillari G, Fiorelli V, Gendelman R, Colombini S, Morris CB, Sgadari C, Markham P, Gallo RC, Ensoli B. HIV-1 Tat protein enhances angiogenesis and Kaposi's sarcoma (KS) development triggered by inflammatory cytokines (IC) or bFGF by engaging theαvβ3 integrin: 68 Journal of Acquired Immune Deficiency Syndromes. 14. DOI: 10.1097/00042560-199704010-00109  0.307
1997 Gallo RC, Lusso P. Chemokines And Hiv Infection Current Opinion in Infectious Diseases. 10: 12-17. DOI: 10.1097/00001432-199702000-00004  0.358
1996 Cocchi F, Devico AL, Garzino-Demo A, Lusso P, Gallo RC. Response: Role of beta-Chemokines in Suppressing HIV Replication. Science (New York, N.Y.). 274: 1394-5. PMID 17772043 DOI: 10.1126/Science.274.5291.1394  0.321
1996 Lisziewicz J, Sun D, Gallo RC, Ensoli B, Lori F. Efficacy of antitat gene therapy in the presence of high multiplicity infection and inflammatory cytokines. Human Gene Therapy. 7: 2209-16. PMID 8953311 DOI: 10.1089/Hum.1996.7.18-2209  0.432
1996 Cocchi F, DeVico AL, Garzino-Demo A, Cara A, Gallo RC, Lusso P. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nature Medicine. 2: 1244-7. PMID 8898753 DOI: 10.1038/Nm1196-1244  0.453
1996 Franchini G, Benson J, Gallo R, Paoletti E, Tartaglia J. Attenuated poxvirus vectors as carriers in vaccines against human T cell leukemia-lymphoma virus type I. Aids Research and Human Retroviruses. 12: 407-408. PMID 8882320 DOI: 10.1089/Aid.1996.12.407  0.397
1996 Flamand L, Zeman RA, Bryant JL, Lunardi-Iskandar Y, Gallo RC. Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 13: 194-7. PMID 8862285 DOI: 10.1097/00042560-199610010-00011  0.389
1996 Myagkikh M, Alipanah S, Markham PD, Tartaglia J, Paoletti E, Gallo RC, Franchini G, Robert-Guroff M. Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques. Aids Research and Human Retroviruses. 12: 985-92. PMID 8827214 DOI: 10.1089/Aid.1996.12.985  0.397
1996 Aksentijevich I, Pastan I, Lunardi-Iskandar Y, Gallo RC, Gottesman MM, Thierry AR. In vitro and in vivo liposome-mediated gene transfer leads to human MDR1 expression in mouse bone marrow progenitor cells. Human Gene Therapy. 7: 1111-22. PMID 8773513 DOI: 10.1089/Hum.1996.7.9-1111  0.311
1996 Gallo RC. Some novel approaches to the control of HIV and select aspects of HIV pathogenesis. Antibiotics and Chemotherapy. 48: 188-91. PMID 8726524 DOI: 10.1159/000425176  0.33
1996 Popescu NC, Zimonjic DB, Leventon-Kriss S, Bryant JL, Lunardi-Iskandar Y, Gallo RC. Deletion and translocation involving chromosome 3 (p14) in two tumorigenic Kaposi's sarcoma cell lines. Journal of the National Cancer Institute. 88: 450-5. PMID 8618237 DOI: 10.1093/Jnci/88.7.450  0.312
1996 Crowley RW, Secchiero P, Zella D, Cara A, Gallo RC, Lusso P. Interference between human herpesvirus 7 and HIV-1 in mononuclear phagocytes. Journal of Immunology (Baltimore, Md. : 1950). 156: 2004-8. PMID 8596056  0.312
1995 Cara A, Guarnaccia F, Reitz MS, Gallo RC, Lori F. Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes. Virology. 208: 242-8. PMID 11831706 DOI: 10.1006/Viro.1995.1148  0.437
1995 Chang HK, Gallo RC, Ensoli B. Regulation of Cellular Gene Expression and Function by the Human Immunodeficiency Virus Type 1 Tat Protein. Journal of Biomedical Science. 2: 189-202. PMID 11725056 DOI: 10.1007/Bf02253380  0.369
1995 Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (New York, N.Y.). 270: 1811-5. PMID 8525373 DOI: 10.1126/Science.270.5243.1811  0.423
1995 Lusso P, Gallo RC. Human herpesvirus 6 in AIDS. Immunology Today. 16: 67-71. PMID 7888069 DOI: 10.1016/0167-5699(95)80090-5  0.365
1995 Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, Gallo RC, Lusso P. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. The Journal of Infectious Diseases. 171: 273-80. PMID 7844362 DOI: 10.1093/Infdis/171.2.273  0.375
1995 Abimiku AG, Franchini G, Aldrich K, Myagkikh M, Markham P, Gard E, Gallo RC, Robert-Guroff M. Humoral and cellular immune responses in rhesus macaques infected with human immunodeficiency virus type 2. Aids Research and Human Retroviruses. 11: 383-93. PMID 7786583 DOI: 10.1089/Aid.1995.11.383  0.488
1995 Gallo RC. A surprising advance in the treatment of viral leukemia. The New England Journal of Medicine. 332: 1783-5. PMID 7760898 DOI: 10.1056/Nejm199506293322611  0.356
1995 Lusso P, Cocchi F, Balotta C, Markham PD, Louie A, Farci P, Pal R, Gallo RC, Reitz MS. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. Journal of Virology. 69: 3712-20. PMID 7745720 DOI: 10.1128/Jvi.69.6.3712-3720.1995  0.423
1995 Franchini G, Tartaglia J, Markham P, Benson J, Fullen J, Wills M, Arp J, Dekaban G, Paoletti E, Gallo RC. Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits. Aids Research and Human Retroviruses. 11: 307-13. PMID 7742044 DOI: 10.1089/Aid.1995.11.307  0.436
1995 Garzino-Demo A, Gallo RC, Arya SK. Human immunodeficiency virus type 2 (HIV-2): packaging signal and associated negative regulatory element. Human Gene Therapy. 6: 177-84. PMID 7734518 DOI: 10.1089/Hum.1995.6.2-177  0.438
1995 Lusso P, Gallo RC. Human herpesvirus 6. Bailliã¨Re's Clinical Haematology. 8: 201-23. PMID 7663047 DOI: 10.1016/S0950-3536(05)80238-0  0.395
1995 Lunardi-Iskandar Y, Gill P, Lam VH, Zeman RA, Michaels F, Mann DL, Reitz MS, Kaplan M, Berneman ZN, Carter D, Bryant JL, Gallo RC. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma Journal of the National Cancer Institute. 87: 974-981. PMID 7629884 DOI: 10.1093/Jnci/87.13.974  0.402
1995 Lisziewicz J, Sun D, Lisziewicz A, Gallo RC. Antitat gene therapy: a candidate for late-stage AIDS patients. Gene Therapy. 2: 218-22. PMID 7614253  0.337
1995 Gallo RC. Human retroviruses in the second decade: a personal perspective. Nature Medicine. 1: 753-9. PMID 7585176 DOI: 10.1038/Nm0895-753  0.305
1995 Maciejewski JP, Weichold FF, Young NS, Cara A, Zella D, Reitz MS, Gallo RC. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nature Medicine. 1: 667-73. PMID 7585149 DOI: 10.1038/Nm0795-667  0.454
1995 Abimiku AG, Franchini G, Tartaglia J, Aldrich K, Myagkikh M, Markham PD, Chong P, Klein M, Kieny M, Paoletti E, Gallo RC, Robert-Guroff M. HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques Nature Medicine. 1: 321-329. PMID 7585061 DOI: 10.1038/Nm0495-321  0.33
1995 Secchiero P, Zella D, Crowley RW, Gallo RC, Lusso P. Quantitative PCR for human herpesviruses 6 and 7. Journal of Clinical Microbiology. 33: 2124-30. PMID 7559960 DOI: 10.1128/Jcm.33.8.2124-2130.1995  0.344
1995 Kaaya EE, Parravicini C, Ordonez C, Gendelman R, Berti E, Gallo RC, Biberfeld P. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 10: 295-305. PMID 7552491 DOI: 10.1097/00042560-199511000-00001  0.347
1995 Weichold FF, Lisziewicz J, Zeman RA, Nerurkar LS, Agrawal S, Reitz MS, Gallo RC. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells. Aids Research and Human Retroviruses. 11: 863-7. PMID 7546914 DOI: 10.1089/Aid.1995.11.863  0.427
1995 Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proceedings of the National Academy of Sciences of the United States of America. 92: 4838-42. PMID 7539135 DOI: 10.1073/Pnas.92.11.4838  0.431
1995 Franchini G, Robert-Guroff M, Tartaglia J, Aggarwal A, Abimiku A, Benson J, Markham P, Limbach K, Hurteau G, Fullen J, Aldrich K, Miller N, Sadoff J, Paoletti E, Gallo RC. Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques. Aids Research and Human Retroviruses. 11: 909-920. PMID 7492438 DOI: 10.1089/Aid.1995.11.909  0.399
1995 Lunardi-Lskandar Y, Bryant JL, Zeman RA, Lam VH, Samaniego F, Besnier JM, Hermans P, Thierry AR, Gill P, Gallo RC. Erratum: Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone (Nature (1995) 375, (64-68)) Nature. 376. DOI: 10.1038/376447A0  0.301
1995 Lori F, Cara A, Malykh AG, Sun D, Lisziewicz J, Weintein J, Gallo RC. Interfering with HIV-1 replication by affecting cellular factors. HIV-1 inhibition by hydroxyurea Antiviral Research. 26. DOI: 10.1016/0166-3542(95)94699-3  0.354
1994 Benson J, Tschachler E, Gessain A, Yanagihara R, Gallo RC, Franchini G. Cross-neutralizing antibodies against cosmopolitan and Melanesian strains of human T cell leukemia/lymphotropic virus type I in sera from inhabitants of Africa and the Solomon Islands. Aids Research and Human Retroviruses. 10: 91-6. PMID 8179967 DOI: 10.1089/Aid.1994.10.91  0.422
1994 Smythe JA, Sun D, Thomson M, Markham PD, Reitz MS, Gallo RC, Lisziewicz J. A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection. Proceedings of the National Academy of Sciences of the United States of America. 91: 3657-61. PMID 8170964 DOI: 10.1073/Pnas.91.9.3657  0.453
1994 Gallo RC. Kaposi's sarcoma, vascular permeability, and scientific integrity. Jama. 272: 916-7; author reply . PMID 8084052 DOI: 10.1001/Jama.1994.03520120026016  0.407
1994 Lisziewicz J, Sun D, Weichold FF, Thierry AR, Lusso P, Tang J, Gallo RC, Agrawal S. Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells. Proceedings of the National Academy of Sciences of the United States of America. 91: 7942-6. PMID 8058738 DOI: 10.1073/Pnas.91.17.7942  0.491
1994 Michaels FH, Gallo RC. Infection of the central nervous system by human retroviruses. Annals of the New York Academy of Sciences. 724: 125-32. PMID 8030931 DOI: 10.1111/J.1749-6632.1994.Tb38900.X  0.314
1994 Secchiero P, Berneman ZN, Gallo RC, Lusso P. Biological and molecular characteristics of human herpesvirus 7: in vitro growth optimization and development of a syncytia inhibition test. Virology. 202: 506-12. PMID 8009865 DOI: 10.1006/Viro.1994.1371  0.416
1994 Lori F, Malykh A, Cara A, Sun D, Weinstein JN, Lisziewicz J, Gallo RC. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science (New York, N.Y.). 266: 801-5. PMID 7973634 DOI: 10.1126/Science.7973634  0.438
1994 Giri A, Markham P, Digilio L, Hurteau G, Gallo RC, Franchini G. Isolation of a novel simian T-cell lymphotropic virus from Pan paniscus that is distantly related to the human T-cell leukemia/lymphotropic virus types I and II. Journal of Virology. 68: 8392-5. PMID 7966632 DOI: 10.1128/Jvi.68.12.8392-8395.1994  0.487
1994 Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, Gallo RC. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature. 371: 674-80. PMID 7935812 DOI: 10.1038/371674A0  0.385
1994 Reitz MS, Popovic M, Saxinger WC, Hall L, Read-Connole E, Markham P, Gallo RC. Partial envelope sequences from some of the earliest isolates of HIV-1. Aids Research and Human Retroviruses. 10: 621-3. PMID 7917524 DOI: 10.1089/Aid.1994.10.621  0.346
1994 Lusso P, Secchiero P, Crowley RW, Garzino-Demo A, Berneman ZN, Gallo RC. CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proceedings of the National Academy of Sciences of the United States of America. 91: 3872-6. PMID 7909607 DOI: 10.1073/Pnas.91.9.3872  0.392
1994 Koralnik IJ, Boeri E, Saxinger WC, Monico AL, Fullen J, Gessain A, Guo HG, Gallo RC, Markham P, Kalyanaraman V. Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission. Journal of Virology. 68: 2693-707. PMID 7908063 DOI: 10.1128/Jvi.68.4.2693-2707.1994  0.333
1994 Abimiku AG, Stern TL, Zwandor A, Markham PD, Calef C, Kyari S, Saxinger WC, Gallo RC, Robert-Guroff M, Reitz MS. Subgroup G HIV type 1 isolates from Nigeria. Aids Research and Human Retroviruses. 10: 1581-3. PMID 7888214 DOI: 10.1089/Aid.1994.10.1581  0.327
1994 Morgan RA, Baler-Bitterlich G, Ragheb JA, Wong-Staal F, Gallo RC, Anderson WF. Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1. Aids Research and Human Retroviruses. 10: 1507-15. PMID 7888205 DOI: 10.1089/Aid.1994.10.1507  0.659
1994 Reitz MS, Hall L, Robert-Guroff M, Lautenberger J, Hahn BM, Shaw GM, Kong LI, Weiss SH, Waters D, Gallo RC. Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB). Aids Research and Human Retroviruses. 10: 1143-55. PMID 7826699 DOI: 10.1089/Aid.1994.10.1143  0.421
1994 Browning PJ, Roberts DD, Zabrenetzky V, Bryant J, Kaplan M, Washington RH, Panet A, Gallo RC, Vogel T. Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu mice. The Journal of Experimental Medicine. 180: 1949-54. PMID 7525844 DOI: 10.1084/Jem.180.5.1949  0.319
1994 Ensoli B, Markham P, Kao V, Barillari G, Fiorelli V, Gendelman R, Raffeld M, Zon G, Gallo RC. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. The Journal of Clinical Investigation. 94: 1736-46. PMID 7525646 DOI: 10.1172/Jci117521  0.359
1994 Browning PJ, Sechler JM, Kaplan M, Washington RH, Gendelman R, Yarchoan R, Ensoli B, Gallo RC. Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls. Blood. 84: 2711-20. PMID 7522639  0.319
1994 Browning PJ, Sechler JMG, Kaplan M, Washington RH, Gendelman R, Yarchoan R, Ensoli B, Gallo RC. Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls [see comments] Blood. 84: 2711-2720. DOI: 10.1182/Blood.V84.8.2711.2711  0.432
1993 Balotta C, Lusso P, Crowley R, Gallo RC, Franchini G. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. Journal of Virology. 67: 4409-14. PMID 8510229 DOI: 10.1128/Jvi.67.7.4409-4414.1993  0.432
1993 Lisziewicz J, Sun D, Metelev V, Zamecnik P, Gallo RC, Agrawal S. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates. Proceedings of the National Academy of Sciences of the United States of America. 90: 3860-4. PMID 8483903 DOI: 10.1073/Pnas.90.9.3860  0.418
1993 Gessain A, Boeri E, Yanagihara R, Gallo RC, Franchini G. Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions. Journal of Virology. 67: 1015-23. PMID 8419636 DOI: 10.1128/Jvi.67.2.1015-1023.1993  0.404
1993 Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. Journal of Virology. 67: 277-87. PMID 8416373 DOI: 10.1128/Jvi.67.1.277-287.1993  0.453
1993 Li G, Lisziewicz J, Sun D, Zon G, Daefler S, Wong-Staal F, Gallo RC, Klotman ME. Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element. Journal of Virology. 67: 6882-8. PMID 8411393 DOI: 10.1128/Jvi.67.11.6882-6888.1993  0.613
1993 Lisziewicz J, Sun D, Smythe J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proceedings of the National Academy of Sciences of the United States of America. 90: 8000-4. PMID 8367455 DOI: 10.1073/Pnas.90.17.8000  0.455
1993 Michaels FH, Hattori N, Gallo RC, Franchini G. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. Aids Research and Human Retroviruses. 9: 1025-30. PMID 8280477 DOI: 10.1089/Aid.1993.9.1025  0.446
1993 Lunardi-Iskandar Y, Gessain A, Lam VH, Gallo RC. Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers. The Journal of Experimental Medicine. 177: 741-50. PMID 8094736 DOI: 10.1084/Jem.177.3.741  0.401
1993 Corbellino M, Lusso P, Gallo RC, Parravicini C, Galli M, Moroni M. Disseminated human herpesvirus 6 infection in AIDS. Lancet. 342: 1242. PMID 7901562 DOI: 10.1016/0140-6736(93)92226-J  0.345
1993 Gao WY, Cara A, Gallo RC, Lori F. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. Proceedings of the National Academy of Sciences of the United States of America. 90: 8925-8. PMID 7692440 DOI: 10.1073/Pnas.90.19.8925  0.407
1993 Barillari G, Gendelman R, Gallo RC, Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proceedings of the National Academy of Sciences of the United States of America. 90: 7941-5. PMID 7690138 DOI: 10.1073/Pnas.90.17.7941  0.41
1993 Reina S, Markham P, Gard E, Rayed F, Reitz M, Gallo RC, Varnier OE. Serological, biological, and molecular characterization of New Zealand white rabbits infected by intraperitoneal inoculation with cell-free human immunodeficiency virus. Journal of Virology. 67: 5367-74. PMID 7688823 DOI: 10.1128/Jvi.67.9.5367-5374.1993  0.433
1993 Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC. Infection of natural killer cells by human herpesvirus 6. Nature. 362: 458-62. PMID 7681936 DOI: 10.1038/362458A0  0.443
1993 Robert-Guroff M, Roilides E, Muldoon R, Venzon D, Husson R, Marshall D, Gallo RC, Pizzo PA. Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value. The Journal of Infectious Diseases. 167: 538-46. PMID 7680059 DOI: 10.1093/Infdis/167.3.538  0.42
1992 Berneman ZN, Gartenhaus RB, Reitz MS, Klotman ME, Gallo RC. cDNA sequencing confirms HTLV-I expression in adult T-cell leukemia/lymphoma and different sequence variations in vivo and in vitro. Leukemia. 6: 67S-71S. PMID 1602830  0.317
1992 Gessain A, Gallo RC, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. Journal of Virology. 66: 2288-95. PMID 1548762 DOI: 10.1128/Jvi.66.4.2288-2295.1992  0.438
1992 Sadaie MR, Kalyanaraman VS, Mukopadhayaya R, Tschachler E, Gallo RC, Wong-Staal F. Biological characterization of noninfectious HIV-1 particles lacking the envelope protein. Virology. 187: 604-11. PMID 1546456 DOI: 10.1016/0042-6822(92)90462-X  0.651
1992 Nair BC, DeVico AL, Nakamura S, Copeland TD, Chen Y, Patel A, O'Neil T, Oroszlan S, Gallo RC, Sarngadharan MG. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science (New York, N.Y.). 255: 1430-2. PMID 1542792 DOI: 10.1126/Science.1542792  0.396
1992 Ensoli B, Barillari G, Gallo RC. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunological Reviews. 127: 147-55. PMID 1506004 DOI: 10.1111/J.1600-065X.1992.Tb01412.X  0.372
1992 Koralnik IJ, Lemp JF, Gallo RC, Franchini G. In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I). Aids Research and Human Retroviruses. 8: 1845-9. PMID 1489573 DOI: 10.1089/Aid.1992.8.1845  0.457
1992 Reitz MS, Guo HG, Oleske J, Hoxie J, Popovic M, Read-Connole E, Markham P, Streicher H, Gallo RC. On the historical origins of HIV-1 (MN) and (RF). Aids Research and Human Retroviruses. 8: 1539-41. PMID 1457197 DOI: 10.1089/Aid.1992.8.1539  0.336
1992 Lisziewicz J, Sun D, Klotman M, Agrawal S, Zamecnik P, Gallo R. Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: An in vitro model for treatment Proceedings of the National Academy of Sciences of the United States of America. 89: 11209-11213. PMID 1454800 DOI: 10.1073/Pnas.89.23.11209  0.446
1992 Barillari G, Buonaguro L, Fiorelli V, Hoffman J, Michaels F, Gallo RC, Ensoli B. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. Journal of Immunology (Baltimore, Md. : 1950). 149: 3727-34. PMID 1431144  0.327
1992 di Marzo Veronese F, Rahman R, Pal R, Boyer C, Romano J, Kalyanaraman VS, Nair BC, Gallo RC, Sarngadharan MG. Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1. Aids Research and Human Retroviruses. 8: 1125-32. PMID 1380259 DOI: 10.1089/Aid.1992.8.1125  0.427
1992 Lori F, di Marzo Veronese F, de Vico AL, Lusso P, Reitz MS, Gallo RC. Viral DNA carried by human immunodeficiency virus type 1 virions. Journal of Virology. 66: 5067-74. PMID 1378514 DOI: 10.1128/Jvi.66.8.5067-5074.1992  0.397
1992 Robert-Guroff M, Aldrich K, Muldoon R, Stern TL, Bansal GP, Matthews TJ, Markham PD, Gallo RC, Franchini G. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. Journal of Virology. 66: 3602-8. PMID 1374810 DOI: 10.1128/Jvi.66.6.3602-3608.1992  0.402
1992 Nakamura S, Sakurada S, Salahuddin SZ, Osada Y, Tanaka NG, Sakamoto N, Sekiguchi M, Gallo RC. Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex. Science (New York, N.Y.). 255: 1437-40. PMID 1371891 DOI: 10.1126/Science.1371891  0.386
1992 Berneman ZN, Gartenhaus RB, Reitz MS, Blattner WA, Manns A, Hanchard B, Ikehara O, Gallo RC, Klotman ME. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proceedings of the National Academy of Sciences of the United States of America. 89: 3005-9. PMID 1348363 DOI: 10.1073/Pnas.89.7.3005  0.406
1992 Hall WW, Takahashi H, Liu C, Kaplan MH, Scheewind O, Ijichi S, Nagashima K, Gallo RC. Multiple isolates and characteristics of human T-cell leukemia virus type II. Journal of Virology. 66: 2456-63. PMID 1347796 DOI: 10.1128/Jvi.66.4.2456-2463.1992  0.458
1992 Berneman ZN, Ablashi DV, Li G, Eger-Fletcher M, Reitz MS, Hung CL, Brus I, Komaroff AL, Gallo RC. Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proceedings of the National Academy of Sciences of the United States of America. 89: 10552-6. PMID 1332051 DOI: 10.1073/Pnas.89.21.10552  0.398
1992 Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC, Ensoli B. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. Journal of Virology. 66: 7159-67. PMID 1279199 DOI: 10.1128/Jvi.66.12.7159-7167.1992  0.383
1991 Marcon L, Michaels F, Hattori N, Fargnoli K, Gallo RC, Franchini G. Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication. Journal of Virology. 65: 3938-42. PMID 2041103 DOI: 10.1128/Jvi.65.7.3938-3942.1991  0.457
1991 Reitz MS, Streicher HZ, Gallo RC. Gallo's virus sequence. Nature. 351: 358. PMID 2034286 DOI: 10.1038/351358A0  0.328
1991 Ensoli B, Barillari G, Gallo RC. Pathogenesis of AIDS-associated Kaposi's sarcoma. Hematology/Oncology Clinics of North America. 5: 281-95. PMID 2022594 DOI: 10.1016/S0889-8588(18)30441-6  0.415
1991 Guo HG, Chermann JC, Waters D, Hall L, Louie A, Gallo RC, Streicher H, Reitz MS, Popovic M, Blattner W. Sequence analysis of original HIV-1. Nature. 349: 745-6. PMID 2000145 DOI: 10.1038/349745A0  0.338
1991 Gessain A, Louie A, Gout O, Gallo RC, Franchini G. Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy. Journal of Virology. 65: 1628-33. PMID 1995955 DOI: 10.1128/Jvi.65.3.1628-1633.1991  0.442
1991 Gartenhaus R, Michaels F, Hall L, Gallo RC, Reitz MS. Relative activities of HIV-1-IIIB and HIV-1BaL LTR and tat in primary monocytes and lymphocytes. Aids Research and Human Retroviruses. 7: 681-8. PMID 1931236 DOI: 10.1089/Aid.1991.7.681  0.401
1991 Gessian A, Yanagihara R, Franchini G, Garruto RM, Jenkins CL, Ajdukiewicz AB, Gallo RC, Gajdusek DC. Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands. Proceedings of the National Academy of Sciences of the United States of America. 88: 7694-8. PMID 1881912 DOI: 10.1073/Pnas.88.17.7694  0.374
1991 Lusso P, De Maria A, Malnati M, Lori F, DeRocco SE, Baseler M, Gallo RC. Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6. Nature. 349: 533-5. PMID 1846951 DOI: 10.1038/349533A0  0.343
1991 Ensoli B, Barillari G, Buonaguro L, Gallo RC. Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma. Advances in Experimental Medicine and Biology. 303: 27-38. PMID 1805571 DOI: 10.1007/978-1-4684-6000-1_4  0.368
1991 DeVico A, Montelaro RC, Gallo RC, Sarngadharan MG. Purification and partial characterization of equine infectious anemia virus reverse transcriptase. Virology. 185: 387-94. PMID 1718086 DOI: 10.1016/0042-6822(91)90786-B  0.421
1991 Gallo RC. Human retroviruses: a decade of discovery and link with human disease. The Journal of Infectious Diseases. 164: 235-43. PMID 1677372 DOI: 10.1093/Infdis/164.2.235  0.355
1991 Josephs SF, Ablashi DV, Salahuddin SZ, Jagodzinski LL, Wong-Staal F, Gallo RC. Identification of the human herpesvirus 6 glycoprotein H and putative large tegument protein genes. Journal of Virology. 65: 5597-604. PMID 1654455 DOI: 10.1128/Jvi.65.10.5597-5604.1991  0.579
1991 Ablashi DV, Balachandran N, Josephs SF, Hung CL, Krueger GR, Kramarsky B, Salahuddin SZ, Gallo RC. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology. 184: 545-52. PMID 1653487  0.321
1991 Flamand L, Gosselin J, D'Addario M, Hiscott J, Ablashi DV, Gallo RC, Menezes J. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. Journal of Virology. 65: 5105-10. PMID 1651426 DOI: 10.1128/Jvi.65.9.5105-5110.1991  0.302
1991 Lisziewicz J, Lusso P, Gallo R, Reitz M. Intracellular immunization against HIV-1 by poly-TAR RNA elements Antiviral Research. 15: 88. DOI: 10.1016/0166-3542(91)90169-R  0.318
1990 Lusso P, Di Marzo Veronese F, Ensoli B, Franchini G, Jemma C, Derocco SE, Kalyanaraman VS, Gallo RC. In Reply: Pseudotypes in HIV-Infected Mice. Science (New York, N.Y.). 250: 1153-4. PMID 17840195 DOI: 10.1126/Science.250.4984.1153  0.338
1990 Buchow HD, Tschachler E, Gallo RC, Reitz M. HIV-I replication requires an intact integrase reading frame. Haematology and Blood Transfusion. 32: 402-5. PMID 2560448 DOI: 10.1007/978-3-642-74621-5_68  0.413
1990 Nara PL, Smit L, Dunlop N, Hatch W, Merges M, Waters D, Kelliher J, Gallo RC, Fischinger PJ, Goudsmit J. Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. Journal of Virology. 64: 3779-91. PMID 2370681 DOI: 10.1128/Jvi.64.8.3779-3791.1990  0.445
1990 Kalyanaraman VS, Rodriguez V, Josephs S, Gallo RC, Sarngadharan MG. Differential viral gene expression and its effect on the biological properties of the cell clones of an HIV-1-infected cell line. Virology. 177: 380-3. PMID 2353462 DOI: 10.1016/0042-6822(90)90495-D  0.43
1990 Wilson C, Reitz MS, Aldrich K, Klasse PJ, Blomberg J, Gallo RC, Robert-Guroff M. The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope. Journal of Virology. 64: 3240-8. PMID 2352323 DOI: 10.1128/Jvi.64.7.3240-3248.1990  0.407
1990 Morgan RA, Looney DJ, Muenchau DD, Wong-Staal F, Gallo RC, Anderson WF. Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. Aids Research and Human Retroviruses. 6: 183-91. PMID 2328156 DOI: 10.1089/Aid.1990.6.183  0.649
1990 Lusso P, di Marzo Veronese F, Ensoli B, Franchini G, Jemma C, DeRocco SE, Kalyanaraman VS, Gallo RC. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science (New York, N.Y.). 247: 848-52. PMID 2305256 DOI: 10.1126/Science.2305256  0.449
1990 Zagury JF, Josephs SF, Agius G, Nicol I, Willer A, Kalyanaraman VS, Zagury D, Wong-Staal F, Gallo RC. In vitro characterization of a biologically active molecular clone of HIV-2NIH-Z containing a nef deletion and expressing a full-length transmembrane protein. Aids Research and Human Retroviruses. 6: 1079-85. PMID 2265026 DOI: 10.1089/Aid.1990.6.1079  0.652
1990 Lusso P, Lori F, Gallo RC. CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. Journal of Virology. 64: 6341-4. PMID 2243398 DOI: 10.1128/Jvi.64.12.6341-6344.1990  0.487
1990 Hattori N, Michaels F, Fargnoli K, Marcon L, Gallo RC, Franchini G. The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proceedings of the National Academy of Sciences of the United States of America. 87: 8080-4. PMID 2236020 DOI: 10.1073/Pnas.87.20.8080  0.478
1990 Pal R, Reitz MS, Tschachler E, Gallo RC, Sarngadharan MG, Veronese FD. Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly. Aids Research and Human Retroviruses. 6: 721-30. PMID 2194551 DOI: 10.1089/Aid.1990.6.721  0.429
1990 Robert-Guroff M, Popovic M, Gartner S, Markham P, Gallo RC, Reitz MS. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. Journal of Virology. 64: 3391-8. PMID 2191150 DOI: 10.1128/Jvi.64.7.3391-3398.1990  0.43
1990 Kalyanaraman VS, Rodriguez V, Veronese F, Rahman R, Lusso P, DeVico AL, Copeland T, Oroszlan S, Gallo RC, Sarngadharan MG. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. Aids Research and Human Retroviruses. 6: 371-80. PMID 2187500 DOI: 10.1089/Aid.1990.6.371  0.359
1990 Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 345: 84-6. PMID 2184372 DOI: 10.1038/345084A0  0.649
1990 Tschachler E, Buchow H, Gallo RC, Reitz MS. Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope. Journal of Virology. 64: 2250-9. PMID 2182910 DOI: 10.1128/Jvi.64.5.2250-2259.1990  0.354
1990 Lusso P, Markham PD, DeRocco SE, Gallo RC. In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo. Journal of Virology. 64: 2751-8. PMID 2159541 DOI: 10.1128/Jvi.64.6.2751-2758.1990  0.453
1990 Bernard J, Reveil B, Najman I, Liautaud-Roger F, Fouchard M, Picard O, Cattan A, Mabondzo A, Laverne S, Gallo RC. Discriminating between protective and enhancing HIV antibodies. Aids Research and Human Retroviruses. 6: 243-9. PMID 2109624 DOI: 10.1089/Aid.1990.6.243  0.394
1990 Guo HG, Veronese FM, Tschachler E, Pal R, Kalyanaraman VS, Gallo RC, Reitz MS. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage. Virology. 174: 217-24. PMID 2104682 DOI: 10.1016/0042-6822(90)90070-8  0.414
1990 Achour A, Picard O, Zagury D, Sarin PS, Gallo RC, Naylor PH, Goldstein AL. HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proceedings of the National Academy of Sciences of the United States of America. 87: 7045-9. PMID 1698289 DOI: 10.1073/Pnas.87.18.7045  0.467
1990 Gallo RC. Concluding Remarks: Human and Related Viruses of Leukemia, Lymphoma, and Immunodeficiency: Biology, Pathogenesis, Treatment, and Prevention Aids Research and Human Retroviruses. 6: 3-6. DOI: 10.1089/Aid.1990.6.3  0.363
1989 Nicol I, Flamminio-Zola G, Dubouch P, Bernard J, Snart R, Jouffre R, Reveil B, Fouchard M, Desportes I, Nara P, Gallo RC, Zagury D. Persistent HIV-2 Infection of Rhesus Macaque, Baboon, and Mangabeys Intervirology. 30: 258-267. PMID 2793399 DOI: 10.1159/000150101  0.395
1989 Barrett N, Mitterer A, Mundt W, Eibl J, Eibl M, Gallo RC, Moss B, Dorner F. Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gp160 and analysis of its immunogenicity. Aids Research and Human Retroviruses. 5: 159-71. PMID 2713166 DOI: 10.1089/Aid.1989.5.159  0.46
1989 Nerurkar LS, Gallo RC. Human retroviruses: cancer and AIDS. International Journal of Cancer. 44: 2-5. PMID 2681008 DOI: 10.1002/Ijc.2910440703  0.305
1989 Gallo RC, Nerurkar LS. Human retroviruses: their role in neoplasia and immunodeficiency. Annals of the New York Academy of Sciences. 567: 82-94. PMID 2679327 DOI: 10.1111/J.1749-6632.1989.Tb16461.X  0.406
1989 Franchini G, Fargnoli KA, Giombini F, Jagodzinski L, De Rossi A, Bosch M, Biberfeld G, Fenyo EM, Albert J, Gallo RC. Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. Proceedings of the National Academy of Sciences of the United States of America. 86: 2433-7. PMID 2648404  0.352
1989 Ensoli B, Nakamura S, Salahuddin SZ, Biberfeld P, Larsson L, Beaver B, Wong-Staal F, Gallo RC. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science (New York, N.Y.). 243: 223-6. PMID 2643161 DOI: 10.1126/Science.2643161  0.581
1989 Yourno J, Fisher AG, Looney DJ, Gallo RC, Wong-Staal F. A recombinant clone of HIV-1 preferentially transmitted in normal peripheral blood mononuclear cells. Aids Research and Human Retroviruses. 5: 565-75. PMID 2575398 DOI: 10.1089/Aid.1989.5.565  0.667
1989 Ensoli B, Lusso P, Schachter F, Josephs SF, Rappaport J, Negro F, Gallo RC, Wong-Staal F. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. The Embo Journal. 8: 3019-27. PMID 2573513 DOI: 10.1002/J.1460-2075.1989.Tb08452.X  0.632
1989 Fox RI, Saito I, Chan EK, Josephs S, Salahuddin SZ, Ahlashi DV, Staal FW, Gallo R, Pei-Ping H, Le CS. Viral genomes in lymphomas of patients with Sjögren's Syndrome Journal of Autoimmunity. 2: 449-455. PMID 2571338 DOI: 10.1016/0896-8411(89)90174-1  0.426
1989 Mann DL, O'Brien SJ, Gilbert DA, Reid Y, Popovic M, Read-Connole E, Gallo RC, Gazdar AF. Origin of the HIV-susceptible human CD4+ cell line H9. Aids Research and Human Retroviruses. 5: 253-5. PMID 2567177 DOI: 10.1089/Aid.1989.5.253  0.37
1989 Cardoso EA, Robert-Guroff M, Franchini G, Gartner S, Moura-Nunes JF, Gallo RC, Terrinha AM. Seroprevalence of HTLV-I in Portugal and evidence of double retrovirus infection of a healthy donor. International Journal of Cancer. Journal International Du Cancer. 43: 195-200. PMID 2563718 DOI: 10.1002/Ijc.2910430204  0.41
1989 Arthur LO, Bess JW, Waters DJ, Pyle SW, Kelliher JC, Nara PL, Krohn K, Robey WG, Langlois AJ, Gallo RC. Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120. Journal of Virology. 63: 5046-53. PMID 2555541 DOI: 10.1128/Jvi.63.12.5046-5053.1989  0.485
1989 Dale JK, Straus SE, Ablashi DV, Salahuddin ZS, Gallo RC, Nishibe Y, Inoue YK. The Inoue-Melnick Virus, Human Herpesvirus Type 6, and the Chronic Fatigue Syndrome Annals of Internal Medicine. 110: 92-93. PMID 2535689 DOI: 10.7326/0003-4819-110-1-92  0.321
1989 Veronese FD, Rahman R, Kalyanaraman VS, Pal R, Lusso P, Tritch R, Petteway S, Gallo RC, Sarngadharan MG. Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1. Aids Research and Human Retroviruses. 5: 479-86. PMID 2480151 DOI: 10.1089/Aid.1989.5.479  0.326
1989 DeVico AL, Copeland TD, Veronese FD, Oroszlan S, Gallo RC, Sarngadharan MG. Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase. Aids Research and Human Retroviruses. 5: 51-60. PMID 2470399 DOI: 10.1089/Aid.1989.5.51  0.415
1989 Fauci AS, Gallo RC, Koenig S, Salk J, Purcell RH. NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection. Annals of Internal Medicine. 110: 373-85. PMID 2464961 DOI: 10.7326/0003-4819-110-5-373  0.425
1989 Veronese FD, Joseph B, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG. Identification of simian immunodeficiency virus SIVMAC env gene products. Journal of Virology. 63: 1416-9. PMID 2464704 DOI: 10.1128/Jvi.63.3.1416-1419.1989  0.37
1989 Lusso P, Ensoli B, Markham PD, Ablashi DV, Salahuddin SZ, Tschachler E, Wong-Staal F, Gallo RC. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature. 337: 370-3. PMID 2463490 DOI: 10.1038/337370A0  0.655
1989 Tschachler E, Robert-Guroff M, Gallo R, Reitz J. Human T-lymphotropic virus I-infected T cells constitutively express lymphotoxin in vitro. Blood. 73: 194-201. DOI: 10.1182/Blood.V73.1.194.194  0.394
1989 Krohn K, Ranki A, Lusso P, Moss B, Ashorn P, Arthur LO, Putney SD, Gallo RC. Proliferative T-Cell Response To Hiv Envelope Glycoprotein In Immunized And Infected Primates And Human-Beings Journal of Medical Primatology. 18: 363-369. DOI: 10.1111/J.1600-0684.1989.Tb00239.X  0.448
1989 Nicol I, Messinger D, Dubouch P, Bernard J, Desportes I, Jouffre R, Snart R, Nara P, Gallo RC, Zagury D. Use of Old World monkeys for acquired immunodeficiency syndrome research. Journal of Medical Primatology. 18: 227-236. DOI: 10.1111/J.1600-0684.1989.Tb00224.X  0.423
1989 Pyle SW, Morein B, Bess JW, Nara PL, Nigida SM, Lerche NW, Gallo RC, Fischinger PJ, Arthur LO. Immune response to immunostimulatory complexes prepared from human immunodeficiency virus and the external envelope glycoprotein Vaccine. 7: 190. DOI: 10.1016/0264-410X(89)90140-0  0.368
1989 Ensoli B, Lusso P, Schachter F, Josephs S, Rappaport J, Negro F, Gallo R, Wong-Staal F. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. The Embo Journal. 8: 3019-3027. DOI: 10.1002/j.1460-2075.1989.tb08452.x  0.346
1988 Blattner W, Gallo RC, Temin HM. HIV causes AIDS Science. 241: 515. PMID 3399881 DOI: 10.1126/Science.3399881  0.336
1988 Yourno J, Josephs SF, Reitz M, Zagury D, Wong-Staal F, Gallo RC. Nucleotide sequence analysis of the env gene of a new Zairian isolate of HIV-1. Aids Research and Human Retroviruses. 4: 165-73. PMID 3395517 DOI: 10.1089/Aid.1988.4.165  0.336
1988 Looney DJ, Fisher AG, Putney SD, Rusche JR, Redfield RR, Burke DS, Gallo RC, Wong-Staal F. Type-restricted neutralization of molecular clones of human immunodeficiency virus. Science (New York, N.Y.). 241: 357-9. PMID 3388046 DOI: 10.1126/Science.3388046  0.643
1988 Gurgo C, Guo HG, Franchini G, Aldovini A, Collalti E, Farrell K, Wong-Staal F, Gallo RC, Reitz MS. Envelope sequences of two new United States HIV-1 isolates. Virology. 164: 531-6. PMID 3369091 DOI: 10.1016/0042-6822(88)90568-5  0.353
1988 Kalyanaraman VS, Pal R, Gallo RC, Sarngadharan MG. A Unique Human Immunodeficiency Virus Culture Secreting Soluble gpl60 Aids Research and Human Retroviruses. 4: 319-329. PMID 3264172 DOI: 10.1089/Aid.1988.4.319  0.445
1988 Nakamura S, Salahuddin SZ, Biberfeld P, Ensoli B, Markham PD, Wong-Staal F, Gallo RC. Kaposi's sarcoma cells: Long-term culture with growth factor from retrovirus-infected CD4+ T cells Science. 242: 426-430. PMID 3262925 DOI: 10.1126/Science.3262925  0.625
1988 Wahren B, Chiodi F, Ljunggren K, Putney S, Kurth R, Gallo RC, Fenyö EM. B and T cell reactivities after immunization of macaques with HIV subcomponents. Aids Research and Human Retroviruses. 4: 199-210. PMID 3260790 DOI: 10.1089/Aid.1988.4.199  0.428
1988 Leonard R, Zagury D, Desportes I, Bernard J, Zagury JF, Gallo RC. Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection Proceedings of the National Academy of Sciences of the United States of America. 85: 3570-3574. PMID 3259321 DOI: 10.1073/Pnas.85.10.3570  0.485
1988 Lusso P, Markham PD, Tschachler E, Veronese FdM, Salahuddin SZ, Ablashi DV, Pahwa S, Krohn K, Gallo RC. In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). Journal of Experimental Medicine. 167: 1659-1670. PMID 3259254 DOI: 10.1084/Jem.167.5.1659  0.412
1988 Robert-Guroff M, Goedert JJ, Naugle CJ, Jennings AM, Blattner WA, Gallo RC. Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: Results of a 6 year prospective study Aids Research and Human Retroviruses. 4: 343-350. PMID 3196490 DOI: 10.1089/Aid.1988.4.343  0.354
1988 Pal R, Gallo RC, Sarngadharan MG. Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin. Proceedings of the National Academy of Sciences of the United States of America. 85: 9283-9286. PMID 3194424 DOI: 10.1073/Pnas.85.23.9283  0.43
1988 Buchbinder A, Josephs SF, Ablashi D, Salahuddin SZ, Klotman ME, Manak M, Krueger GRF, Wong-Staal F, Gallo RC. Polymerase chain reaction amplification and in situ hybridization for the detection of human B-lymphotropic virus Journal of Virological Methods. 21: 191-197. PMID 3182954 DOI: 10.1016/0166-0934(88)90065-1  0.325
1988 Josephs SF, Ablashi DV, Salahuddin SZ, Kramarsky B, Franza BR, Pellett P, Buchbinder A, Memon S, Wong-Staal F, Gallo RC. Molecular studies of HHV-6 Journal of Virological Methods. 21: 179-190. PMID 3182953 DOI: 10.1016/0166-0934(88)90064-X  0.339
1988 Zagury D, Bernard J, Cheynier R, Desportes I, Leonard R, Fouchard M, Reveil B, Ittele D, Lurhuma Z, Mbayo K, Wane J, Salaun J, Goussard B, Dechazal L, Burny A, ... ... Gallo RC, et al. A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS Nature. 332: 728-731. PMID 3162762 DOI: 10.1038/332728A0  0.417
1988 Veronese FD, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. Journal of Virology. 62: 795-801. PMID 3123712 DOI: 10.1128/Jvi.62.3.795-801.1988  0.396
1988 Ablashi DV, Lusso P, Hung C, Salahuddin SZ, Josephs SF, Llana T, Kramarsky B, Biberfeld P, Markham PD, Gallo RC. Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). International Journal of Cancer. 42: 787-791. PMID 3053468 DOI: 10.1002/Ijc.2910420526  0.428
1988 Desgranges C, Boyer V, Souche S, Sprecher S, Burny A, Gallo RC, Bernard J, Reveil B, Zagury D. Monoclonal Antibodies To Hiv In A Non-Infected, Immunised Volunteer The Lancet. 331: 935-936. PMID 2895850 DOI: 10.1016/S0140-6736(88)91737-0  0.453
1988 Arya SK, Gallo RC. Human immunodeficiency virus type 2 long terminal repeat: analysis of regulatory elements Proceedings of the National Academy of Sciences of the United States of America. 85: 9753-9757. PMID 2849115 DOI: 10.1073/Pnas.85.24.9753  0.384
1988 Krueger GRF, Koch B, Ramon A, Ablashi DV, Salahuddin SZ, Josephs SF, Streicher HZ, Gallo RC, Habermann U. Antibody prevalence to HBLV (human herpesvirus-6, HHV-6) and suggestive pathogenicity in the general population and in patients with immune deficiency syndromes. Journal of Virological Methods. 21: 125-131. PMID 2846608 DOI: 10.1016/0166-0934(88)90059-6  0.351
1988 Fisher AG, Ensoli B, Looney D, Rose A, Gallo RC, Saag MS, Shaw GM, Hahn BH, Wong-Staal F. Biologically diverse molecular variants within a single HIV-1 isolate Nature. 334: 444-447. PMID 2841608 DOI: 10.1038/334444A0  0.655
1988 Reitz MS, Wilson C, Naugle C, Gallo RC, Robert-Guroff M. Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell. 54: 57-63. PMID 2838179 DOI: 10.1016/0092-8674(88)90179-1  0.361
1988 Gallo R, Wong-Staal F, Montagnier L, Haseltine WA, Yoshida M. HIV/HTLV gene nomenclature [4] Nature. 333: 504. PMID 2836736 DOI: 10.1038/333504A0  0.565
1988 Clark JW, Gurgo C, Franchini G, Gibbs WN, Lofters W, Neuland C, Mann D, Saxinger C, Gallo RC, Blattner WA. Molecular epidemiology of HTLV-I-associated non-Hodgkin's lymphomas in Jamaica. Cancer. 61: 1477-1482. PMID 2830960 DOI: 10.1002/1097-0142(19880401)61:7<1477::Aid-Cncr2820610735>3.0.Co;2-X  0.359
1988 Salahuddin S, Nakamura S, Biberfeld P, Kaplan M, Markham P, Larsson L, Gallo R. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro Science. 242: 430-433. PMID 2459779 DOI: 10.1126/Science.2459779  0.372
1988 Minassian AA, Kalyanaraman VS, Gallo RC, Popovic M. Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus. Proceedings of the National Academy of Sciences of the United States of America. 85: 6939-6943. PMID 2457921 DOI: 10.1073/Pnas.85.18.6939  0.409
1988 Berzofsky JA, Bensussant A, Cease KB, Bourge JF, Cheynier R, Lurhuma Z, Salaün JJ, Gallo RC, Shearer GM, Zaguryi D. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans. Nature. 334: 706-708. PMID 2457809 DOI: 10.1038/334706A0  0.391
1988 Cheynier R, Soulha M, Laure F, Vol JC, Reveil B, Gallo RC, Sarin PS, Zagury D. HIV-1 Expression by T8 Lymphocytes After Transfection Aids Research and Human Retroviruses. 4: 43-50. PMID 2452649 DOI: 10.1089/Aid.1988.4.43  0.401
1988 DeVICO AL, Veronese FDM, Lee SL, Gallo RC, Sarngadharan MG. High prevalence of serum antibodies to reverse transcriptase in HIV-1-infected individuals. Aids Research and Human Retroviruses. 4: 17-22. PMID 2452648 DOI: 10.1089/Aid.1988.4.17  0.358
1988 Rusche JR, Javaherian K, McDanal C, Petro J, Lynn DL, Grimaila R, Langlois A, Gallo RC, Arthur LO, Fischinger PJ. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proceedings of the National Academy of Sciences of the United States of America. 85: 3198-202. PMID 2452447 DOI: 10.1073/Pnas.85.9.3198  0.429
1987 Guo HG, Franchini G, Collalti E, Beaver B, Gurgo C, Gallo RC, Wong-Staal F, Reitz MS. Structure of the long terminal repeat of simian lymphotropic virus type III (African green monkey) and its relatedness to that of HIV. Aids Research and Human Retroviruses. 3: 177-85. PMID 3650101 DOI: 10.1089/Aid.1987.3.177  0.391
1987 Ablashi DV, Salahuddin SZ, Josephs SF, Imam F, Lusso P, Gallo RC, Hung C, Lemp J, Markham PD. HBLV (orHHV-6) in human cell lines Nature. 329: 207-207. PMID 3627265 DOI: 10.1038/329207A0  0.328
1987 Fisher AG, Ensoli B, Ivanoff L, Chamberlain M, Petteway S, Ratner L, Gallo RC, Wong-Staal F. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science. 237: 888-893. PMID 3497453 DOI: 10.1126/Science.3497453  0.462
1987 Franchini G, Gurgo C, Guo HG, Gallo RC, Collalti E, Fargnoli KA, Hall LF, Wong-Staal F, Reitz MS. Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses. Nature. 328: 539-43. PMID 3497350 DOI: 10.1038/328539A0  0.481
1987 Manca N, Veronese FdM, Ho DD, Gallo RC, Sarngadharan MG. Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects. European Journal of Epidemiology. 3: 96-102. PMID 3497054 DOI: 10.1007/Bf00239745  0.38
1987 Kaplan MH, Susin M, Pahwa SG, Fetten J, Allen SL, Lichtman S, Sarngadharan MG, Gallo RC. Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors The American Journal of Medicine. 82: 389-396. PMID 3493690 DOI: 10.1016/0002-9343(87)90435-9  0.36
1987 Saxinger C, Alter HJ, Eichberg JW, Fauci AS, Robey WG, Gallo RC. Stages in the progression of HIV infection in chimpanzees. Aids Research and Human Retroviruses. 3: 375-385. PMID 3482160 DOI: 10.1089/Aid.1987.3.375  0.379
1987 Heisig V, Benter T, Josephs SF, Sadaie MR, Okamoto T, Gallo RC, Wong-Staal F. Interaction of viral and cellular factors with the HTLV-III LTR target sequences in vitro. Haematology and Blood Transfusion. 31: 423-429. PMID 3481758 DOI: 10.1007/978-3-642-72624-8_90  0.311
1987 Veronese FDM, Rahman R, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG. Immunological and Chemical Analysis of P6, the Carboxyl-Terminal Fragment of HIV P15 Aids Research and Human Retroviruses. 3: 253-264. PMID 3481270 DOI: 10.1089/Aid.1987.3.253  0.339
1987 Arthur LO, Pyle SW, Nara PL, Bess JW, Gonda MA, Kelliher JC, Gilden RV, Robey WG, Bolognesi DP, Gallo RC. Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine. Proceedings of the National Academy of Sciences of the United States of America. 84: 8583-7. PMID 3479807 DOI: 10.1073/Pnas.84.23.8583  0.456
1987 Rusche JR, Lynn DL, Robert-Guroff M, Langlois AJ, Lyerly HK, Carson H, Krohn K, Ranki A, Gallo RC, Bolognesi DP. Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells Proceedings of the National Academy of Sciences of the United States of America. 84: 6924-6928. PMID 3477816 DOI: 10.1073/Pnas.84.19.6924  0.451
1987 Robert-Guroff M, Oleske JM, Connor EM, Epstein LG, Minnefor AB, Gallo RC. Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases Pediatric Research. 21: 547-550. PMID 3474582 DOI: 10.1203/00006450-198706000-00008  0.316
1987 Ratner L, Fisher A, Jagodzinski LL, Liou RS, Mitsuya H, Gallo RC, Wong-Staal F. Complete nucleotide sequences of functional clones of the virus associated with the acquired immunodeficiency syndrome, HTLV-III/LAV. Haematology and Blood Transfusion. 31: 404-406. PMID 3443402 DOI: 10.1007/978-3-642-72624-8_86  0.365
1987 Franchini G, Collalti E, Arya SK, Fenyo EM, Biberfeld G, Zagury JF, Kanki PJ, Wong-Staal F, Gallo RC. Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-III(AGM) Aids Research and Human Retroviruses. 3: 11-17. PMID 3040052 DOI: 10.1089/Aid.1987.3.11  0.426
1987 Wahren B, Morfeldt-Månsson L, Biberfeld G, Moberg L, Sönnerborg A, Ljungman P, Werner A, Kurth R, Gallo R, Bolognesi D. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection Journal of Virology. 61: 2017-2023. PMID 3033328 DOI: 10.1128/Jvi.61.6.2017-2023.1987  0.435
1987 Gallo RC, Robert-Guroff M, Wong-Staal F, Reitz MS, Arya SK, Streicher HZ. HTLV-III/LAV and the origin and pathogenesis of AIDS. International Archives of Allergy and Applied Immunology. 82: 471-5. PMID 3032803 DOI: 10.1159/000234257  0.315
1987 Salahuddin SZ, Hunter EA, Sturzenegger S, Markham PD, Gallo RC, Ablashi DV, Gonda MA. HTLV‐III infection of EBV‐genome‐positive B‐lymphoid cells with or without detectable T4 antigens International Journal of Cancer. 39: 198-202. PMID 3026971 DOI: 10.1002/Ijc.2910390213  0.403
1987 Gurgo C, Gallo RC. Human retroviruses: HTLV-I, II, and III and their association with leukemia and AIDS. Annals of the New York Academy of Sciences. 511: 350-369. PMID 2894191 DOI: 10.1111/J.1749-6632.1987.Tb36264.X  0.305
1987 Gallo RC. Human tumor and immunodeficiency viruses. Aids Research and Human Retroviruses. 3: 187-196. PMID 2891363 DOI: 10.1089/Aid.1987.3.187  0.324
1987 Lusso P, Salahuddin SZ, Ablashi DV, Gallo RC, Veronese FDM, Markham PD. Diverse Tropism Of Human B-Lymphotropic Virus (Human Herpesvirus 6) The Lancet. 330: 743-744. PMID 2888966 DOI: 10.1016/S0140-6736(87)91103-2  0.364
1987 Macchi B, Popovic M, Allavena P, Ortaldo J, Rossi P, Gallo RC, Bonmassar E. In vitro susceptibility of different human T-cell subpopulations and resistance of large granular lymphocytes to HTLV-I infection. International Journal of Cancer. 40: 1-6. PMID 2885278 DOI: 10.1002/Ijc.2910400102  0.445
1987 Mann D, DeSantis P, Mark G, Pfeifer A, Newman M, Gibbs N, Popovic M, Sarngadharan M, Gallo R, Clark J. HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis. Science. 236: 1103-1106. PMID 2883731 DOI: 10.1126/Science.2883731  0.441
1987 Gibbs WN, Lofters WS, Campbell M, Hanchard B, LaGRENADE L, Cranston B, Hendriks J, Jaffe ES, Saxinger C, Robert-Guroff M, Gallo RC, Clark J, Blattner WA. Non-Hodgkin Lymphoma in Jamaica and its Relation to Adult T-Cell Leukemia-Lymphoma Annals of Internal Medicine. 106: 361-368. PMID 2880536 DOI: 10.7326/0003-4819-106-3-361  0.403
1987 Matthews TJ, Langlois AJ, Robey WG, Chang NT, Gallo RC, Fischinger PJ, Bolognesi DP. Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein Hamatologie Und Bluttransfusion. 31: 414-422. PMID 2832276 DOI: 10.1007/978-3-642-72624-8_89  0.383
1987 Gurgo C, Robert-Guroff M, Gallo RC. An Overview of the Human T-Lymphotropic Retroviruses and the Role of HTLV-III/LAV in AIDS1 Antibiotics and Chemotherapy. 38: 1-12. PMID 2821878 DOI: 10.1159/000414214  0.351
1987 Laure F, Leonard R, Mbayo K, Lurhuma Z, Kayembe N, Brechot C, Sarin PS, Sarngadharan M, Wong-Staal F, Gallo RC, Zagury D. Genomic diversity of Zairian HIV isolates: biological characteristics and clinical manifestation of HIV infection. Aids Research and Human Retroviruses. 3: 343-353. PMID 2451928 DOI: 10.1089/Aid.1987.3.343  0.418
1987 Krohn K, Robey WG, Putney S, Arthur L, Nara P, Fischinger P, Gallo RC, Wong-Staal F, Ranki A. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. Proceedings of the National Academy of Sciences of the United States of America. 84: 4994-8. PMID 2440037 DOI: 10.1073/Pnas.84.14.4994  0.475
1987 Cease KB, Margalit H, Cornette JL, Putney SD, Robey WG, Ouyang C, Streicher HZ, Fischinger PJ, Gallo RC, DeLisi C. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide Proceedings of the National Academy of Sciences of the United States of America. 84: 4249-4253. PMID 2438696 DOI: 10.1073/Pnas.84.12.4249  0.401
1987 Modrow S, Hahn BH, Shaw GM, Gallo RC, Wong-Staal F, Wolf H. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: Prediction of antigenic epitopes in conserved and variable regions Journal of Virology. 61: 570-578. PMID 2433466 DOI: 10.1128/Jvi.61.2.570-578.1987  0.406
1987 Graziani G, Pasqualetti D, Lopez M, D'Onofrio C, Testi A, Mandelli F, Gallo R, Bonmassar E. Increased susceptibility of peripheral mononuclear cells of leukemic patients to HTLV-I infection in vitro. Blood. 69: 1175-1181. DOI: 10.1182/Blood.V69.4.1175.1175  0.365
1987 Biberfeld P, Kramarsky B, Salahuddin SZ, Gallo RC. Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) isolated from patients with lymphoproliferative disease. Journal of the National Cancer Institute. 79: 933-941. DOI: 10.1093/Jnci/79.5.933  0.459
1987 BIBERFELD G, BROWN F, ESPARZA J, ESSEX M, GALLO RC, MONTAGNIER L, NAJERA R, RISSER R, SCHILD G. WHO Working Group on Characterization of HIV-Related Retroviruses: Criteria for Characterization and Proposal for a Nomenclature System Aids Research and Human Retroviruses. 3: 241-243. DOI: 10.1089/Aid.1987.3.241  0.321
1987 Gallo RC. The AIDS virus. Scientific American. 256: 46-56. DOI: 10.1038/Scientificamerican0187-46  0.381
1987 Gallo RC, Sarngadharan MG, Arya SK, Wong-Staal F. Human retroviruses with emphasis on HTLV-III/LAV: Now and future perspectives Annales De L'Institut Pasteur. Virologie. 138: 13-19. DOI: 10.1016/S0769-2617(87)80069-2  0.309
1987 Bartholomew C, Saxinger WC, Clark JW, Gail M, Dudgeon A, Mahabir B, Hull-Drysdale B, Cleghorn F, Gallo RC, Blattner WA. Transmission of HTLV-I and HIV among homosexual men in Trinidad. Jama. 257: 2604-2608. DOI: 10.1001/Jama.1987.03390190082024  0.397
1986 Fujikawa LS, Salahuddin SZ, Ablashi D, Palestine AG, Masur H, Nussenblatt RB, Gallo RC. HTLV-III in the tears of AIDS patients Ophthalmology. 93: 1479-1481. PMID 3643502 DOI: 10.1016/S0161-6420(86)33531-0  0.423
1986 Feinberg MB, Jarrett RF, Aldovini A, Gallo RC, Wong-Staal F. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell. 46: 807-17. PMID 3638988 DOI: 10.1016/0092-8674(86)90062-0  0.382
1986 Blick M, Westin E, Wong-Staal F, Gallo R, McCredie K, Gutterman J. Rearrangement and enhanced expression of c-myc oncogene in fresh tumor cells obtained from a patient with acute lymphoblastic leukemia. Leukemia Research. 10: 381-387. PMID 3457223 DOI: 10.1016/0145-2126(86)90067-6  0.355
1986 Pahwa S, Pahwa R, Good RA, Gallo RC, Saxinger C. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes Proceedings of the National Academy of Sciences of the United States of America. 83: 9124-9128. PMID 3024167 DOI: 10.1073/Pnas.83.23.9124  0.486
1986 Josephs S, Salahuddin S, Ablashi D, Schachter F, Wong-Staal F, Gallo R. Genomic analysis of the human B-lymphotropic virus (HBLV). Science. 234: 601-603. PMID 3020691 DOI: 10.1126/Science.3020691  0.396
1986 Fisher AG, Ratner L, Mitsuya H, Marselle LM, Harper ME, Broder S, Gallo RC, Wong-Staal F. Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects. Science (New York, N.Y.). 233: 655-9. PMID 3014663 DOI: 10.1126/Science.3014663  0.448
1986 Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection Science. 233: 215-219. PMID 3014648 DOI: 10.1126/Science.3014648  0.433
1986 Hahn BH, Shaw GM, Taylor ME, Redfield RR, Markham PD, Salahuddin SZ, Wong-Staal F, Gallo RC, Parks ES, Parks WP. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS Science. 232: 1548-1553. PMID 3012778 DOI: 10.1126/Science.3012778  0.382
1986 Sundqvist V-, Linde A, Kurth R, Werner A, Helm EB, Popovic M, Gallo RC, Wahren B. Restricted IgG Subclass Responses to HTLV-III/LAV and to Cytomegalovirus in Patients with AIDS and Lymphadenopathy Syndrome The Journal of Infectious Diseases. 153: 970-973. PMID 3009638 DOI: 10.1093/Infdis/153.5.970  0.446
1986 Arya SK, Gallo RC. Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proceedings of the National Academy of Sciences of the United States of America. 83: 2209-2213. PMID 3008154 DOI: 10.1073/Pnas.83.7.2209  0.382
1986 Chakrabarti S, Robert-Guroff M, Wong-Staal F, Gallo RC, Moss B. Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature. 320: 535-7. PMID 3008001 DOI: 10.1038/320535A0  0.4
1986 Fisher AG, Feinberg MB, Josephs SF, Harper ME, Marselle LM, Reyes G, Gonda MA, Aldovini A, Debouk C, Gallo RC. The trans-activator gene of HTLV-III is essential for virus replication. Nature. 320: 367-71. PMID 3007995 DOI: 10.1038/320367A0  0.409
1986 Gallo RC, Sliski AH, Noronha CMCD, Noronha FD. Origins of human T-lymphotropic viruses. Nature. 320: 219-219. PMID 3007990 DOI: 10.1038/320219A0  0.38
1986 Melbye M, Biggar RJ, Ebbesen P, Neuland C, Goedert JJ, Faber V, Lorenzen I, Skinhøj P, Gallo RC, Blattner WA. Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Annals of Internal Medicine. 104: 496-500. PMID 3006568 DOI: 10.7326/0003-4819-104-4-496  0.33
1986 Newman MJ, Baker IT, Reitz MS, Eiden M, Blattner WA, Gallo RC, Mann DL. Serological characterization of human T-cell leukemia (lymphotropic) virus, type I (HTLV-I) small envelope protein. Virology. 150: 106-16. PMID 3006330 DOI: 10.1016/0042-6822(86)90270-9  0.37
1986 Harper ME, Marselle LM, Gallo RC, Wong-Staal F. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization Proceedings of the National Academy of Sciences of the United States of America. 83: 772-776. PMID 3003749 DOI: 10.1073/Pnas.83.3.772  0.391
1986 Markham PD, Salahuddin SZ, Veren K, Orndorff S, Gallo RC. Hydrocortisone and some other hormones enhance the expression of HTLV-III. International Journal of Cancer. 37: 67-72. PMID 3000956 DOI: 10.1002/Ijc.2910370112  0.403
1986 Abrams DI, Kiprov DD, Goedert JJ, Sarngadharan MG, Gallo RC, Volberding PA. Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Annals of Internal Medicine. 104: 47-50. PMID 3000249 DOI: 10.7326/0003-4819-104-1-47  0.403
1986 Fouchard M, Reveil B, Mbayo K, Lurhuma A, Sarin PS, Gallo RC, Zagury D. Evidence for HTLV-III/LAV expression by primary cultures of T8 cells. International Journal of Cancer. 38: 657-659. PMID 2945790 DOI: 10.1002/Ijc.2910380507  0.434
1986 Wantzin GL, Thomsen K, Nissen NI, Saxinger C, Gallo RC. Occurrence of human T cell lymphotropic virus (type I) antibodies in cutaneous T cell lymphoma Journal of the American Academy of Dermatology. 15: 598-602. PMID 2877013 DOI: 10.1016/S0190-9622(86)70210-7  0.414
1986 Salahuddin S, Ablashi D, Markham P, Josephs S, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo R. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders Science. 234: 596-601. PMID 2876520 DOI: 10.1126/Science.2876520  0.447
1986 Harper ME, Kaplan MH, Marselle LM, Pahwa SG, Chayt KJ, Sarngadharan MG, Wong-Staal F, Gallo RC. Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease. The New England Journal of Medicine. 315: 1073-1078. PMID 2876381 DOI: 10.1056/Nejm198610233151707  0.43
1986 Matthews TJ, Langlois AJ, Robey WG, Chang NT, Gallo RC, Fischinger PJ, Bolognesi DP. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein Proceedings of the National Academy of Sciences of the United States of America. 83: 9709-9713. PMID 2432599 DOI: 10.1073/Pnas.83.24.9709  0.421
1986 De Rossi A, Franchini G, Aldovini A, Del Mistro A, Chieco-Bianchi L, Gallo RC, Wong-Staal F. Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. Proceedings of the National Academy of Sciences of the United States of America. 83: 4297-301. PMID 2424024 DOI: 10.1073/PNAS.83.12.4297  0.362
1986 Gonda MA, Braun MJ, Clements JE, Pyper JM, Wong-Staal F, Gallo RC, Gilden RV. Human T-cell lymphotropic virus type III shares sequence homology with a family of pathogenic lentiviruses Proceedings of the National Academy of Sciences of the United States of America. 83: 4007-4011. PMID 2424014 DOI: 10.1073/Pnas.83.11.4007  0.413
1986 Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks ES, Parks WP, Josephs SF, Gallo RC, Wong-Staal F. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS Cell. 45: 637-648. PMID 2423250 DOI: 10.1016/0092-8674(86)90778-6  0.314
1986 Veronese FDM, Copeland TD, Devico AL, Rahman R, Oroszlan S, Gallo RC, Sarngadharan MG. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV Science. 231: 1289-1291. PMID 2418504 DOI: 10.1126/Science.2418504  0.322
1986 Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin P, Gallo R. Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science. 231: 850-853. PMID 2418502 DOI: 10.1126/Science.2418502  0.422
1986 Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood. 68: 281-284. DOI: 10.1182/Blood.V68.1.281.Bloodjournal681281  0.446
1986 Groopman J, Sullivan J, Mulder C, Ginsburg D, Orkin S, O'Hara C, Falchuk K, Wong-Staal F, Gallo R. Pathogenesis of B Cell Lymphoma in a Patient With AIDS Blood. 67: 612-615. DOI: 10.1182/Blood.V67.3.612.612  0.434
1986 Gallo RC, Wong-Staal F. A Human T-Lymphotropic Retrovirus (HTLV-III) as the Cause of the Acquired Immunodeficiency Syndrome The Journal of Urology. 136: 548-548. DOI: 10.1016/S0022-5347(17)44963-9  0.36
1986 Gallo RC, Popovic M, Sarngadharan MG. Serological detection of antibodies to HTLV-III in sera of patients with AIDS and pre-AIDS conditions International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. 13. DOI: 10.1016/0883-2897(86)90118-2  0.414
1986 Chayt KJ, Harper ME, Marselle LM, Lewin EB, Rose RM, Oleske JM, Epstein LG, Wong-Staal F, Gallo RC. Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. Jama. 256: 2356-2359. DOI: 10.1001/Jama.1986.03380170072021  0.396
1986 Robert-Guroff M, Weiss SH, Giron JA, Jennings AM, Ginzburg HM, Margolis IB, Blattner WA, Gallo RC. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. Jama. 255: 3133-3137. DOI: 10.1001/Jama.1986.03370220095034  0.326
1986 Pahwa S, Kaplan M, Fikrig S, Pahwa R, Sarngadharan MG, Popovic M, Gallo RC. Spectrum of Human T-Cell Lymphotropic Virus Type III Infection in Children: Recognition of Symptomatic, Asymptomatic, and Seronegative Patients Jama: the Journal of the American Medical Association. 255: 2299-2305. DOI: 10.1001/Jama.1986.03370170063036  0.364
1986 Stevens CE, Taylor PE, Zang EA, Morrison JM, Harley EJ, Cordoba SRd, Bacino C, Ting RCY, Bodner AJ, Sarngadharan MG, Gallo RC, Rubinstein P. Human T-Cell Lymphotropic Virus Type III Infection in a Cohort of Homosexual Men in New York City Jama. 255: 2167-2172. DOI: 10.1001/Jama.1986.03370160065028  0.399
1985 Olsson I, Gullberg U, Sarngadharan MG, Gallo RC. A T lymphocyte-derived differentiation-inducing factor for myeloid leukemia cells: purification and characterization. Haematology and Blood Transfusion. 29: 423-425. PMID 3875528 DOI: 10.1007/978-3-642-70385-0_86  0.367
1985 Lindner SG, Rahman R, Sarngadharan MG, Gallo RC. Purification of normal human T-cell growth factor to molecular homogeneity. Haematology and Blood Transfusion. 29: 396-397. PMID 3875525 DOI: 10.1007/978-3-642-70385-0_81  0.396
1985 Arya SK, Gallo RC. Human T-cell growth factor (interleukin 2) and gamma-interferon genes: expression in human T-lymphotropic virus type III- and type I-infected cells. Proceedings of the National Academy of Sciences of the United States of America. 82: 8691-8695. PMID 3001715 DOI: 10.1073/Pnas.82.24.8691  0.447
1985 Franchini G, Mann DL, Popovic M, Zicht RR, Gallo RC, Wong-staal F. HTLV-I infection of T and B cells of a patient with adult T-cell leukemia-lymphoma (ATLL) and transmission of HTLV-I from B cells to normal T cells. Leukemia Research. 9: 1305-1314. PMID 3001435 DOI: 10.1016/0145-2126(85)90116-X  0.441
1985 Redfield RR, James WD, Wright DC, Brown C, Salahuddin SZ, Markham PD, Sarngadharan MG, Folks TF, Gallo RC. Severe molluscum contagiosum infection in a patient with human T cell lymphotrophic (HTLV-III) disease. Journal of the American Academy of Dermatology. 13: 821-4. PMID 3001156 DOI: 10.1016/S0190-9622(85)80397-2  0.396
1985 James WD, Redfield RR, Lupton GP, Meltzer MS, Berger TG, Rodman OG, Markham PD, Sarngadharan MG, Salahuddin SZ, Gallo RC. A papular eruption associated with human T cell lymphotropic virus type III disease. Journal of the American Academy of Dermatology. 13: 563-6. PMID 3001155 DOI: 10.1016/S0190-9622(85)70197-1  0.407
1985 Pahwa S, Pahwa R, Saxinger C, Gallo RC, Good RA. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: Evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations Proceedings of the National Academy of Sciences of the United States of America. 82: 8198-8202. PMID 2999797 DOI: 10.1073/Pnas.82.23.8198  0.483
1985 Robert-Guroff M, Clark J, Lanier AP, Beckman G, Melbye M, Ebbesen P, Blattner WA, Gallo RC. Prevalence of HTLV‐I in arctic regions International Journal of Cancer. 36: 651-655. PMID 2999005 DOI: 10.1002/Ijc.2910360605  0.314
1985 Broder S, Gallo RC. Human T-cell leukemia viruses (HTLV): a unique family of pathogenic retroviruses. Annual Review of Immunology. 3: 321-336. PMID 2998418 DOI: 10.1146/Annurev.Iy.03.040185.001541  0.316
1985 Rossi Ad, Aldovini A, Franchini G, Mann D, Gallo RC, Wong-Staal F. Clonal selection of T lymphocytes infected by cell-free human T-cell leukemia/lymphoma virus type I: Parameters of virus integration and expression Virology. 143: 640-645. PMID 2998031 DOI: 10.1016/0042-6822(85)90405-2  0.453
1985 Koprowski H, DeFreitas EC, Harper ME, Sandberg-Wollheim M, Sheremata WA, Robert-Guroff M, Saxinger CW, Feinberg MB, Wong-Staal F, Gallo RC. Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature. 318: 154-60. PMID 2997627 DOI: 10.1038/318154A0  0.416
1985 Shearer GM, Salahuddin SZ, Markham PD, Joseph LJ, Payne SM, Kriebel P, Bernstein DC, Biddison WE, Sarngadharan MG, Gallo RC. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. The Journal of Clinical Investigation. 76: 1699-704. PMID 2997287 DOI: 10.1172/Jci112158  0.397
1985 Gallo RC, Wong-Staal F. A human T-lymphotropic retrovirus (HTLV-III) as the cause of the acquired immunodeficiency syndrome. Annals of Internal Medicine. 103: 679-689. PMID 2996399 DOI: 10.7326/0003-4819-103-5-679  0.473
1985 Fujikawa LS, Salahuddin SZ, Ablashi D, Palestine AG, Masur H, Nussenblatt RB, Gallo RC. Human T-Cell Leukemia/Lymphotropic Virus Type III in the Conjunctival Epithelium of a Patient With AIDS American Journal of Ophthalmology. 100: 507-509. PMID 2996356 DOI: 10.1016/0002-9394(85)90671-3  0.443
1985 Markham PD, Shaw GM, Salahuddin SZ, Hahn B, Sarngadharan MG, Gallo RC. Etiology of AIDS: biological and biochemical characteristics of HTLV-III. Advances in Experimental Medicine and Biology. 187: 13-34. PMID 2994417 DOI: 10.1007/978-1-4615-9430-7_2  0.397
1985 Goldstein AL, Naylor PH, Schulof RS, Simon GL, Sztein MB, Kessler CM, Robert-Guroff M, Gallo RC. Thymosin in the staging and treatment of HTLV-III positive homosexuals and hemophiliacs with AIDS-related immune dysfunction. Advances in Experimental Medicine and Biology. 187: 129-40. PMID 2994416 DOI: 10.1007/978-1-4615-9430-7_14  0.362
1985 Veronese FD, Devico AL, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG. Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science. 229: 1402-1405. PMID 2994223 DOI: 10.1126/Science.2994223  0.347
1985 Aoki T, Hamada C, Ohno S, Miyakoshi H, Kaneko Y, Robert-Guroff M, Ting RC, Gallo RC. Roles of HTLV-I p19 and natural antibody to HTLV-I in host immune responses. Haematology and Blood Transfusion. 29: 342-344. PMID 2993130 DOI: 10.1007/978-3-642-70385-0_72  0.415
1985 Gallo RC, Sarngadharan MG, Popovic M, Schupbach J, Markham P, Salahuddin SZ, Shaw G, Wong-Staal F, Reitz MS. The human T-cell leukemia virus family, adult T cell leukemia, and AIDS. Haematology and Blood Transfusion. 29: 317-25. PMID 2993125 DOI: 10.1007/978-3-642-70385-0_67  0.47
1985 Sandstrom EG, Schooley RT, Ho DD, Byington R, Sarngadharan MG, MacLane ME, Essex M, Gallo RC, Hirsch MS. Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion. 25: 308-12. PMID 2992128 DOI: 10.1046/J.1537-2995.1985.25485273806.X  0.355
1985 Wong-Staal F, Shaw G, Hahn B, Salahuddin S, Popovic M, Markham P, Redfield R, Gallo R. Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science. 229: 759-762. PMID 2992084 DOI: 10.1126/Science.2992084  0.412
1985 Salahuddin SZ, Markham PD, Popovic M, Sarngadharan MG, Orndorff S, Fladagar A, Patel A, Gold J, Gallo RC. Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proceedings of the National Academy of Sciences of the United States of America. 82: 5530-5534. PMID 2991931 DOI: 10.1073/Pnas.82.16.5530  0.462
1985 Veronese FdM, Sarngadharan MG, Rahman R, Markham PD, Popovic M, Bodner AJ, Gallo RC. Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III Proceedings of the National Academy of Sciences of the United States of America. 82: 5199-5202. PMID 2991911 DOI: 10.1073/Pnas.82.15.5199  0.419
1985 Hahn BH, Gonda MA, Shaw GM, Popovic M, Hoxie JA, Gallo RC, Wong-Staal F. Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: Different viruses exhibit greatest divergence in their envelope genes Proceedings of the National Academy of Sciences of the United States of America. 82: 4813-4817. PMID 2991896 DOI: 10.1073/Pnas.82.14.4813  0.389
1985 Sodroski JG, Goh WC, Rosen CA, Salahuddin SZ, Aldovini A, Franchini G, Wong-Staal F, Gallo RC, Sugamura K, Hinuma Y. trans-Activation of the human T-cell leukemia virus long terminal repeat correlates with expression of the x-lor protein Journal of Virology. 55: 831-835. PMID 2991599 DOI: 10.1128/Jvi.55.3.831-835.1985  0.431
1985 Aiuti F, Rossi P, Sirianni MC, Carbonari M, Popovic M, Sarngadharan MG, Contu L, Moroni M, Romagnani S, Gallo RC. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy. Bmj. 291: 165-166. PMID 2990634 DOI: 10.1136/Bmj.291.6489.165  0.333
1985 Robert-Guroff M, Brown M, Gallo RC. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature. 316: 72-74. PMID 2989707 DOI: 10.1038/316072A0  0.406
1985 Blattner WA, Gallo RC. Epidemiology of human retroviruses. Leukemia Research. 9: 697-698. PMID 2989622 DOI: 10.1016/0145-2126(85)90277-2  0.3
1985 Clark JW, Hahn BH, Mann DL, Wong-Staal F, Popovic M, Richardson E, Strong DM, Lofters WS, Blattner WA, Gibbs WN, Gallo RC. Molecular and immunologic analysis of a chronic lymphocytic leukemia case with antibodies against human T-cell leukemia virus. Cancer. 56: 495-499. PMID 2988745 DOI: 10.1002/1097-0142(19850801)56:3<495::Aid-Cncr2820560314>3.0.Co;2-H  0.473
1985 Sarin PS, Gallo RC. Cellular transformation by human T cell leukemia retroviruses (HTLV) Pharmacology and Therapeutics. 27: 49-62. PMID 2987983 DOI: 10.1016/0163-7258(85)90064-6  0.357
1985 Vecchis LD, Graziani G, Macchi B, Grandori C, Pastore S, Popovic M, Gallo RC, Bonmassar E. Decline of natural cytotoxicity of human lymphocytes following infection with human T-cell leukemia/lymphoma virus (HTLV). Leukemia Research. 9: 349-355. PMID 2987620 DOI: 10.1016/0145-2126(85)90056-6  0.452
1985 Chang NT, Huang J, Ghrayeb J, McKinney S, Chanda PK, Chang TW, Putney S, Sarngadharan MG, Wong-Staal F, Gallo RC. An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS. Nature. 315: 151-154. PMID 2986016 DOI: 10.1038/315151A0  0.406
1985 Robey WG, Safai B, Oroszlan S, Arthur LO, Gonda MA, Gallo RC, Fischinger PJ. Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science (New York, N.Y.). 228: 593-5. PMID 2984774 DOI: 10.1126/Science.2984774  0.353
1985 Robert-Guroff M, Markham PD, Popovic M, Gallo RC. Isolation, characterization, and biological effects of the first human retroviruses: the human T-lymphotropic retrovirus family. Current Topics in Microbiology and Immunology. 115: 7-31. PMID 2983948 DOI: 10.1007/978-3-642-70113-9_2  0.415
1985 Blattner WA, Gallo RC. Human T-Cell Leukemia/Lymphoma Viruses: Clinical and Epidemiologic Features Current Topics in Microbiology and Immunology. 115: 67-88. PMID 2983947 DOI: 10.1007/978-3-642-70113-9_5  0.388
1985 Saxinger WC, Levine PH, Dean AG, De Thé G, Lange-Wantzin G, Moghissi J, Laurent F, Hoh M, Sarngadharan MG, Gallo RC. Evidence for exposure to HTLV-III in Uganda before 1973 Science. 227: 1036-1038. PMID 2983417 DOI: 10.1126/Science.2983417  0.357
1985 Ratner L, Gallo RC, Wong-Staal F. HTLV-III, LAV, ARV are variants of same AIDS virus [8] Nature. 313: 636-637. PMID 2983217 DOI: 10.1038/313636C0  0.389
1985 Aoki T, Miyakoshi H, Koide H, Yoshida T, Ishikawa H, Sugisaki Y, Mizukoshi M, Tamura K, Misawa H, Hamada C, Ting RC, Robert-Guroff M, Gallo RC. Seroepidemilogy of human T-lymphotropic retrovirus type I (HTLV-I) in residents of niigata prefecture, Japan. Comparative studies by indirect immunofluorescence microscopy and enzyme-linked immunosorbent assay International Journal of Cancer. 35: 301-306. PMID 2982747 DOI: 10.1002/Ijc.2910350304  0.326
1985 Groopman JE, Mayer KH, Sarngadharan MG, Ayotte D, Devico AL, Finberg R, Sliski AH, Allan JD, Gallo RC. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. Annals of Internal Medicine. 102: 334-337. PMID 2982305 DOI: 10.7326/0003-4819-102-3-334  0.345
1985 Groopman JE, Sarngadharan MG, Salahuddin SZ, Buxbaum R, Huberman MS, Kinniburgh J, Sliski A, McLane MF, Essex M, Gallo RC. Apparent transmission of human T-cell leukemia virus type III to a heterosexual woman with the acquired immunodeficiency syndrome. Annals of Internal Medicine. 102: 63-6. PMID 2981497 DOI: 10.7326/0003-4819-102-1-63  0.416
1985 Starcich B, Ratner L, Josephs SF, Okamoto T, Gallo RC, Wong-Staal F. Characterization of long terminal repeat sequences of HTLV-III. Science (New York, N.Y.). 227: 538-40. PMID 2981438 DOI: 10.1126/Science.2981438  0.41
1985 Gonda MA, Wong-Staal F, Gallo RC, Clements JE, Narayan O, Gilden RV. Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science (New York, N.Y.). 227: 173-7. PMID 2981428 DOI: 10.1126/Science.2981428  0.452
1985 Sodroski J, Rosen C, Wong-Staal F, Salahuddin SZ, Popovic M, Arya S, Gallo RC, Haseltine WA. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science (New York, N.Y.). 227: 171-3. PMID 2981427 DOI: 10.1126/Science.2981427  0.464
1985 Schüpbach J, Haller O, Vogt M, Lüthy R, Joller H, Oelz O, Popovic M, Sarngadharan MG, Gallo RC. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. The New England Journal of Medicine. 312: 265-270. PMID 2981407 DOI: 10.1056/Nejm198501313120502  0.39
1985 Broder S, Collins J, Markham P, Redfield R, Hoth D, Groopman J, Gallo R, Yarchoan R, Lane HC, Klecker R, Mitsuya H, Gelmann E, Resnick L, Myers C, Fauci A. Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo The Lancet. 326: 627-630. PMID 2863631 DOI: 10.1016/S0140-6736(85)90002-9  0.366
1985 Perre PVD, Carael M, Robert-Guroff M, Clumeck N, Nzabihimana E, Mol PD, Freyens P, Gallo R, Butzler J, Kanyamupira J. Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III The Lancet. 326: 524-527. PMID 2863544 DOI: 10.1016/S0140-6736(85)90462-3  0.324
1985 Zagury D, Fouchard M, Vol J, Cattan A, Leibowitch J, Feldman M, Sarin P, Gallo R. Detection Of Infectious Htlv-Iii/Lav Virus In Cell-Free Plasma From Aids Patients The Lancet. 326: 505-506. PMID 2863528 DOI: 10.1016/S0140-6736(85)90442-8  0.412
1985 Zagury D, Gagne I, Brigitteréveil, Bernard J, Zagury J, Saimot AG, Sarin P, Gallo R. Repairing The T-Cell Defect In Aids The Lancet. 326: 449-449. PMID 2863475 DOI: 10.1016/S0140-6736(85)92770-9  0.325
1985 Clark J, Ensroth A, Blattner WA, Saxinger C, Robert-Guroff M, Gallo RC, Gibbs WN, Lofters W, Lagranade L, Deceulaer K. Seroepidemiologic studies of human T-cell leukemia/lymphoma virus type I in Jamaica. International Journal of Cancer. 36: 37-41. PMID 2862109 DOI: 10.1002/Ijc.2910360107  0.32
1985 Gajdusek DC, Amyx HL, Gibbs CJ, Asher DM, Rodgers-Johnson P, Epstein LG, Sarin PS, Gallo RC, Maluish A, Arthur LO. Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients. Lancet. 1: 55-6. PMID 2856985 DOI: 10.1016/S0140-6736(85)91011-6  0.435
1985 Sarngadharan MG, Bruch L, Popovic M, Gallo RC. Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III). Proceedings of the National Academy of Sciences of the United States of America. 82: 3481-3484. PMID 2582414 DOI: 10.1073/Pnas.82.10.3481  0.334
1985 Pompidou A, Zagury D, Gallo R, Sun D, Thornton A, Sarin P. In-Vitro Inhibition Of Lav/Htlv-Iii Infected Lymphocytes By Dithiocarb And Inosine Pranobex The Lancet. 326: 1423. PMID 2417079 DOI: 10.1016/S0140-6736(85)92585-1  0.32
1985 Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Lehrman SN, Gallo RC, Bolognesi D, Barry DW, Broder S. 3'-Azido-3'-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro Proceedings of the National Academy of Sciences of the United States of America. 82: 7096-7100. PMID 2413459 DOI: 10.1073/pnas.82.20.7096  0.366
1985 Wong-Staal F, Gallo RC. Human T-lymphotropic retroviruses. Nature. 317: 395-403. PMID 2413364 DOI: 10.1038/317395A0  0.424
1985 Fujikawa LS, Salahuddin SZ, Palestine AG, Masur H, Nussenblatt RB, Gallo RC. Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. The Lancet. 326: 529-530. PMID 2412078 DOI: 10.1016/S0140-6736(85)90464-7  0.43
1985 Laure F, Zagury D, Saimot AG, Gallo RC, Hahn BH, Brechot C. Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex Science. 229: 561-563. PMID 2410981 DOI: 10.1126/Science.2410981  0.377
1985 Fisher AG, Collalti E, Ratner L, Gallo RC, Wong-Staal F. A molecular clone of HTLV-III with biological activity. Nature. 316: 262-5. PMID 2410792 DOI: 10.1038/316262A0  0.444
1985 Pahwa S, Fikrig S, Kaplan M, Popovic M, Sarngaharan A, Gallo R, Pahwa R. 1016 Spectrum Of Htlv-Iii Infection In Children Pediatric Research. 19. DOI: 10.1203/00006450-198504000-01046  0.348
1985 Hattori T, Robert-Guroff M, Chosa T, Matsuoka M, Yamaguchi K, Ishii T, Gallo R, Takatsuki K. Natural antibodies in sera from Japanese individuals infected with HTLV- I do not recognize HTLV-III Blood. 66: 745-747. DOI: 10.1182/Blood.V66.3.745.745  0.415
1985 Groopman J, Hartzband P, Shulman L, Salahuddin S, Sarngadharan M, McLane M, Essex M, Gallo R. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)- infected patients with acquired immunodeficiency syndrome or related disorders Blood. 66: 742-744. DOI: 10.1182/Blood.V66.3.742.742  0.417
1985 McDougal J, Jaffe H, Cabridilla C, Sarngadharan M, Nicholson J, Kalyanaraman V, Schable C, Kilbourne B, Evatt B, Gallo R. Screening tests for blood donors presumed to have transmitted the acquired immunodeficiency syndrome Blood. 65: 772-775. DOI: 10.1182/Blood.V65.3.772.Bloodjournal653772  0.334
1985 Goedert J, Sarngadharan M, Eyster M, Weiss S, Bodner A, Gallo R, Blattner W. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. Blood. 65: 492-495. DOI: 10.1182/Blood.V65.2.492.492  0.339
1985 Wong-Staal F, Gallo RC. The family of human T-lymphotropic leukemia viruses: HTLV-I as the cause of adult T cell leukemia and HTLV-III as the cause of acquired immunodeficiency syndrome. Blood. 65: 253-263. DOI: 10.1182/Blood.V65.2.253.Bloodjournal652253  0.388
1985 Ratner L, Josephs SF, Starcich B, Hahn B, Shaw GM, Gallo RC, Wong-Staal F. Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I. Journal of Virology. 54: 781-790. DOI: 10.1128/Jvi.54.3.781-790.1985  0.442
1985 Peng JW, Bunn PA, Knutsen T, Shan CSK, Broder S, Jaffe ES, Gelmann E, Blattner W, Lofters W, Young RC, Gallo RC. Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States. Journal of the National Cancer Institute. 74: 357-369. DOI: 10.1093/Jnci/74.2.357  0.344
1985 Chang TW, Kato I, McKinney S, Chanda P, Barone AD, Wong-Staal F, Gallo RC, Chang NT. Detection of Antibodies to Human T-Cell Lymphotropic Virus-III (HTLV-III) with an Immunoassay Employing a Recombinant Escherichia coli -Derived Viral Antigenic Peptide Nature Biotechnology. 3: 905-909. DOI: 10.1038/Nbt1085-905  0.38
1985 Wong-Staal F, Ratner L, Shaw G, Hahn B, Harper M, Franchini G, Gallo R. Molecular Biology of Human T-Lymphotropic Retroviruses Cancer Research. 45: 293-304. DOI: 10.1007/978-1-4684-5242-6_24  0.437
1985 Redfield RR, Markham PD, Salahuddin SZ, Wright DC, Sarngadharan MG, Gallo RC. Heterosexually acquired HTLV-III/LAV disease (AIDS-related complex and AIDS). Epidemiologic evidence for female-to-male transmission. Jama. 254: 2094-2096. DOI: 10.1001/Jama.1985.03360150070026  0.315
1985 Weiss SH, Saxinger WC, Rechtman D, Grieco MH, Nadler J, Holman S, Ginzburg HM, Groopman JE, Goedert JJ, Markham PD, Gallo RC, Blattner WA, Landesman S. HTLV-III Infection Among Health Care Workers: Association With Needle-Stick Injuries Jama: the Journal of the American Medical Association. 254: 2089-2093. DOI: 10.1001/Jama.1985.03360150065025  0.31
1985 Jaffe HW, Sarngadharan MG, DeVico AL, Bruch L, Getchell JP, Kalyanaraman VS, Haverkos HW, Stoneburner RL, Gallo RC, Curran JW. Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an association. Jama. 254: 770-773. DOI: 10.1001/Jama.1985.03360060072028  0.41
1985 Eyster ME, Goedert JJ, Sarngadharan MG, Weiss SH, Gallo RC, Blattner WA. Development and early natural history of HTLV-III antibodies in persons with hemophilia. Jama. 253: 2219-2223. DOI: 10.1001/Jama.1985.03350390061026  0.429
1985 Redfield RR, Markham PD, Salahuddin SZ, Sarngadharan MG, Bodner AJ, Folks TM, Ballou WR, Wright DC, Gallo RC. Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS. Jama. 253: 1571-1573. DOI: 10.1001/Jama.1985.03350350065021  0.422
1984 Arya SK, Gallo RC. Transcriptional modulation of human T-cell growth factor gene by phorbol ester and interleukin 1. Biochemistry. 23: 6685-6690. PMID 6335665 DOI: 10.1021/Bi00321A062  0.376
1984 Krönke M, Leonard WJ, Depper JM, Arya SK, Wong-Staal F, Gallo RC, Waldmann TA, Greene WC. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proceedings of the National Academy of Sciences of the United States of America. 81: 5214-8. PMID 6332315 DOI: 10.1073/Pnas.81.16.5214  0.345
1984 Mann DL, Clark J, Clarke M, Reitz M, Popovic M, Franchini G, Trainor CD, Strong DM, Blattner WA, Gallo RC. Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemia Journal of Clinical Investigation. 74: 56-62. PMID 6330177 DOI: 10.1172/Jci111418  0.387
1984 Greaves MF, Verbi W, Tilley R, Lister TA, Habeshaw J, Guo H‐, Trainor CD, Robert‐Guroff M, Blattner W, Reitz M, Gallo RC. Human T-cell leukaemia virus (HTLV) in the United Kingdom International Journal of Cancer. 33: 795-806. PMID 6329969 DOI: 10.1002/Ijc.2910330614  0.455
1984 Clarke MF, Trainor CD, Mann DL, Gallo RC, Reitz MS. Methylation of human T-cell leukemia virus proviral DNA and viral RNA expression in short- and long-term cultures of infected cells Virology. 135: 97-104. PMID 6328756 DOI: 10.1016/0042-6822(84)90120-X  0.398
1984 Nakao Y, Maeda S, Matsuda S, Takubo T, Masaoka T, Shiozawa S, Sugiyama T, Ito Y, Sarin PS, Gallo RC. Detection of human T-cell leukemia virus antibodies in a Japanese T-cell leukemia patient with hypercalcemia. Cancer. 54: 259-265. PMID 6327003 DOI: 10.1002/1097-0142(19840715)54:2<259::Aid-Cncr2820540213>3.0.Co;2-V  0.414
1984 Williams CK, Alabi GO, Junaid TA, Saxinger C, Gallo RC, Blayney DW, Blattner WA, Greaves MF. Human T cell leukaemia virus associated lymphoproliferative disease: report of two cases in Nigeria. Bmj. 288: 1495-1496. PMID 6326929 DOI: 10.1136/Bmj.288.6429.1495  0.385
1984 Jaffe ES, Blattner WA, Blayney DW, Bunn PA, Cossman J, Robert-guroff M, Gallo RC. The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Human T-cell leukemia/lymphoma virus-associated lymphoid malignancies. The American Journal of Surgical Pathology. 8: 263-276. PMID 6324600 DOI: 10.1097/00000478-198404000-00003  0.396
1984 Schupbach J, Sarngadharan M, Gallo R. Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein Science. 224: 607-610. PMID 6324349 DOI: 10.1126/Science.6324349  0.475
1984 Sarngadharan MG, Popovic M, Bruch L, Schupbach J, Gallo RC. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS Science. 224: 506-508. PMID 6324345 DOI: 10.1126/Science.6324345  0.457
1984 Clarke MF, Westin E, Schmidt D, Josephs SF, Ratner L, Wong-Staal F, Gallo RC, Reitz MS. Transformation of NIH 3T3 cells by a human c-sis cDNA clone. Nature. 308: 464-7. PMID 6323994 DOI: 10.1038/308464A0  0.406
1984 Palker TJ, Scearce RM, Miller SE, Popovic M, Bolognesi DP, Gallo RC, Haynes BF. Monoclonal antibodies against human T cell leukemia-lymphoma virus (HTLV) p24 internal core protein. Use as diagnostic probes and cellular localization of HTLV Journal of Experimental Medicine. 159: 1117-1131. PMID 6323615 DOI: 10.1084/Jem.159.4.1117  0.452
1984 Broder S, Bunn PA, Jaffe ES, Blattner W, Gallo RC, Wong-Staal F, Waldmann TA, DeVITA VT. T-Cell Lymphoproliferative Syndrome Associated with Human T-Cell Leukemia/Lymphoma Virus Annals of Internal Medicine. 100: 543-557. PMID 6322632 DOI: 10.7326/0003-4819-100-4-543  0.442
1984 Guo HG, Wong-Stall F, Gallo RC. Novel viral sequences related to human T-cell leukemia virus in T cells of a seropositive baboon. Science (New York, N.Y.). 223: 1195-7. PMID 6322297 DOI: 10.1126/SCIENCE.6322297  0.364
1984 Gelmann EP, Franchini G, Manzari V, Wong-Staal F, Gallo RC. Molecular cloning of a unique human T-cell leukemia virus (HTLV-IIMo). Proceedings of the National Academy of Sciences of the United States of America. 81: 993-7. PMID 6322194 DOI: 10.1073/Pnas.81.4.993  0.475
1984 Arya SK, Wong-Staal F, Gallo RC. T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells. Science. 223: 1086-1087. PMID 6320374 DOI: 10.1126/Science.6320374  0.441
1984 Salahuddin S, Markham P, Lindner S, Gootenberg J, Popovic M, Hemmi H, Sarin P, Gallo R. Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I Science. 223: 703-707. PMID 6320367 DOI: 10.1126/Science.6320367  0.4
1984 Aoki T, Hamada C, Ohno S, Miyakoshi H, Koide H, Robert-Guroff M, Ting RC, Gallo RC. Location of human T-cell leukemia virus (HTLV) p19 antigen on virus-producing cells International Journal of Cancer. 33: 161-165. PMID 6319298 DOI: 10.1002/Ijc.2910330202  0.452
1984 Markham PD, Salahuddin SZ, Macchi B, Robert‐Guroff M, Gallo RC. Transformation of different phenotypic types of human bone marrow T‐lymphocytes by htlv‐1 International Journal of Cancer. 33: 13-17. PMID 6319295 DOI: 10.1002/Ijc.2910330104  0.397
1984 Seigel LJ, Harper ME, Wong-Staal F, Gallo RC, Nash WG, O'Brien SJ. Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1 Science. 223: 175-178. PMID 6318318 DOI: 10.1126/Science.6318318  0.353
1984 Zagury D, Bernard J, Leibowitch J, Safai B, Groopman J, Feldman M, Sarngadharan M, Gallo R. HTLV-III in cells cultured from semen of two patients with AIDS Science. 226: 449-451. PMID 6208607 DOI: 10.1126/Science.6208607  0.46
1984 Sodroski J, Patarca R, Perkins D, Briggs D, Lee TH, Essex M, Coligan J, Wong-Staal F, Gallo RC, Haseltine WA. Sequence of the envelope glycoprotein gene of type II human T lymphotropic virus. Science (New York, N.Y.). 225: 421-4. PMID 6204380 DOI: 10.1126/Science.6204380  0.387
1984 Schupbach J, Popovic M, Gilden RV, Gonda MA, Sarngadharan MG, Gallo RC. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS Science. 224: 503-505. PMID 6200937 DOI: 10.1126/Science.6200937  0.411
1984 Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS Science. 224: 500-503. PMID 6200936 DOI: 10.1126/Science.6200936  0.39
1984 Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS Science. 224: 497-500. PMID 6200935 DOI: 10.1126/Science.6200935  0.475
1984 Kalyanaraman VS, Jarvis-Morar M, Sarngadharan MG, Gallo RC. Immunological characterization of the low molecular weight gag gene proteins p19 and p15 of human T-cell leukemia-lymphoma virus (HTLV) and demonstration of human natural antibodies to them. Virology. 132: 61-70. PMID 6198803 DOI: 10.1016/0042-6822(84)90091-6  0.388
1984 Popovic M, Read-Connole E, Gallo R. T4 Positive Human Neoplastic Cell Lines Susceptible To And Permissive For Htlv-Iii The Lancet. 324: 1472-1473. PMID 6151082 DOI: 10.1016/S0140-6736(84)91666-0  0.377
1984 Melbye M, Madhok R, Sarin P, Lowe GO, Goedert J, Froebel K, Biggar R, Stenbjerg S, Forbes C, Gallo R, Ebbesen P. Htlv-Iii Seropositivity In European Haemophiliacs Exposed To Factor Viii Concentrate Imported From The Usa The Lancet. 324: 1444-1446. PMID 6151053 DOI: 10.1016/S0140-6736(84)91632-5  0.351
1984 Salahuddin SZ, Markham P, Redfield R, Essex M, Groopman J, Sarngadharan MG, Mclane M, Sliski A, Gallo R. HTLV-III in symptom-free seronegative persons. The Lancet. 324: 1418-1420. PMID 6151041 DOI: 10.1016/S0140-6736(84)91619-2  0.414
1984 Krohn K, Ranki A, Antonen J, Valle S, Suni J, Vaheri A, Saxinger C, Gallo R. Immune functions in HTLV-III antibody positive homosexual men without clinical AIDS. The Lancet. 324: 746-747. PMID 6148491 DOI: 10.1016/S0140-6736(84)92647-3  0.376
1984 Goedert JJ, Biggar RJ, Winn DM, Greene MH, Mann DL, Gallo RC, Sarngadharan MG, Weiss SH, Grossman RJ, Bodner AJ, Strong DM, Blattner WA. Determinants Of Retrovirus (Htlv-Iii) Antibody And Immunodeficiency Conditions In Homosexual Men The Lancet. 324: 711-716. PMID 6148471 DOI: 10.1016/S0140-6736(84)92624-2  0.379
1984 Robert-Guroff M, Safai B, Gelmann E, Mansell PA, Groopman J, Sidhu G, Friedman-Kien A, Bayley A, Blayney D, Lange M, Gutterman J, Goedert J, Steigbigel N, Johnson J, Downing R, ... Gallo R, et al. HTLV-I-specific antibody in AIDS patients and others at risk. The Lancet. 324: 128-131. PMID 6146035 DOI: 10.1016/S0140-6736(84)91047-X  0.337
1984 Safai B, Sarngadharan MG, Groopman JE, Arnett K, Popovic M, Sliski A, Schüpbach J, Gallo RC. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet (London, England). 1: 1438-40. PMID 6145881 DOI: 10.1016/S0140-6736(84)91933-0  0.42
1984 Gajdusek DC, Amyx HL, Gibbs CJ, Asher DM, Yanagihara RT, Rodgers-Johnson P, Brown PW, Sarin PS, Gallo RC, Maluish A. Transmission experiments with human T-lymphotropic retroviruses and human AIDS tissue. Lancet. 1: 1415-6. PMID 6145867 DOI: 10.1016/S0140-6736(84)91916-0  0.335
1984 Mitsuya H, Megson M, Mann D, Matis L, Cohen O, Gallo R, Broder S. Immune T Cells Reactive Against Human T-Cell Leukaemia/Lymphoma Virus The Lancet. 323: 649-652. PMID 6142349 DOI: 10.1016/S0140-6736(84)92169-X  0.427
1984 Schüpbach J, Sarngadharan MG, Blayney D, Kalyanaraman VS, Bunn P, Gallo R. Demonstration of viral antigen p24 in circulating immune complexes of two patients with human T-cell leukaemia/lymphoma virus (HTLV) positive lymphoma. The Lancet. 323: 302-305. PMID 6141379 DOI: 10.1016/S0140-6736(84)90358-1  0.396
1984 Markham PD, Sarngadharan MG, Salahuddin SZ, Popovic M, Gallo RC. Correlation Between Exposure to Human: T-Cell Leukemia-Lymphoma Virus-Iii and the Development of Aids Annals of the New York Academy of Sciences. 437: 106-109. PMID 6099996 DOI: 10.1111/J.1749-6632.1984.Tb37127.X  0.434
1984 Josephs SF, Wong-Staal F, Manzari V, Gallo RC, Sodroski JG, Trus MD, Perkins D, Patarca R, Haseltine WA. Long terminal repeat structure of an american isolate of type I human T-cell leukemia virus Virology. 139: 340-345. PMID 6097028 DOI: 10.1016/0042-6822(84)90379-9  0.376
1984 Sarin PS, Gallo RC. Human T-lymphotropic retroviruses in adult T-cell leukemia-lymphoma and acquired immune deficiency syndrome Journal of Clinical Immunology. 4: 415-423. PMID 6096392 DOI: 10.1007/Bf00916570  0.44
1984 Sarin PS, Gallo RC. Retroviruses in human t-cell malignancies Cancer Investigation. 2: 467-478. PMID 6095972 DOI: 10.3109/07357908409048520  0.389
1984 Shaw G, Hahn B, Arya S, Groopman J, Gallo R, Wong-Staal F. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science. 226: 1165-1171. PMID 6095449 DOI: 10.1126/Science.6095449  0.432
1984 Lee TH, Coligan JE, McLane MF, Sodroski JG, Popovic M, Wong-Staal F, Gallo RC, Haseltine W, Essex M. Serological cross-reactivity between envelope gene products of type I and type II human T-cell leukemia virus Proceedings of the National Academy of Sciences of the United States of America. 81: 7579-7583. PMID 6095307 DOI: 10.1073/Pnas.81.23.7579  0.462
1984 Suciu-Foca N, Rubinstein P, Popovic M, Gallo RC, King DW. Reactivity of HTLV-transformed human T-cell lines to MHC class II antigens Nature. 312: 275-277. PMID 6095090 DOI: 10.1038/312275A0  0.426
1984 Hahn BH, Shaw GM, Arya SK, Popovic M, Gallo RC, Wong-Staal F. Molecular cloning and characterization of the HTLV-III virus associated with AIDS Nature. 312: 166-169. PMID 6095086 DOI: 10.1038/312166A0  0.434
1984 Hahn BH, Shaw GM, Popovic M, Monico AL, Gallo RC, Wong‐Staal F. Molecular cloning and analysis of a new variant of human T-cell leukemia virus (HTLV-ib) from an African patient with adult T-cell leukemia-lymphoma. International Journal of Cancer. 34: 613-618. PMID 6094362 DOI: 10.1002/Ijc.2910340505  0.423
1984 Alter H, Eichberg J, Masur H, Saxinger W, Gallo R, Macher A, Lane H, Fauci A. Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS Science. 226: 549-552. PMID 6093251 DOI: 10.1126/Science.6093251  0.392
1984 Popovic M, Flomenberg N, Volkman DJ, Mann D, Fauci AS, Dupont B, Gallo RC. Alteration of T-cell functions by infection with HTLV-I or HTLV-II. Science (New York, N.Y.). 226: 459-62. PMID 6093248 DOI: 10.1126/Science.6093248  0.426
1984 Groopman J, Salahuddin S, Sarngadharan M, Markham P, Gonda M, Sliski A, Gallo R. HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS Science. 226: 447-449. PMID 6093247 DOI: 10.1126/Science.6093247  0.418
Show low-probability matches.